Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1989 Oct;98(Suppl):606P–773P.

Proceedings of the British Pharmacological Society. Leeds, 12th-14th July 1989. Abstracts.

PMCID: PMC1950871  PMID: 2775936

Full text

PDF
606P

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ARUNLAKSHANA O., SCHILD H. O. Some quantitative uses of drug antagonists. Br J Pharmacol Chemother. 1959 Mar;14(1):48–58. doi: 10.1111/j.1476-5381.1959.tb00928.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. ARUNLAKSHANA O., SCHILD H. O. Some quantitative uses of drug antagonists. Br J Pharmacol Chemother. 1959 Mar;14(1):48–58. doi: 10.1111/j.1476-5381.1959.tb00928.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Adams G. E., Barnes D. W., du Boulay C., Loutit J. F., Cole S., Sheldon P. W., Stratford I. J., van den Aardweg G. J., Hopewell J. W., White R. D. Induction of hypoxia in normal and malignant tissues by changing the oxygen affinity of hemoglobin--implications for therapy. Int J Radiat Oncol Biol Phys. 1986 Aug;12(8):1299–1302. doi: 10.1016/0360-3016(86)90158-6. [DOI] [PubMed] [Google Scholar]
  4. Adamson P., Hajimohamadreza I., Brammer M. J., Campbell I. C. Intrasynaptosomal free calcium concentration is increased by phorbol esters via a 1,4-dihydropyridine-sensitive (L-type) Ca2+ channel. Eur J Pharmacol. 1989 Mar 14;162(1):59–66. doi: 10.1016/0014-2999(89)90604-3. [DOI] [PubMed] [Google Scholar]
  5. Agnes M., Lung K. Y., Wang J. C. Effects of prostaglandin E1 on canine nasal vascular and airway resistances. J Pharmacol Exp Ther. 1984 Jan;228(1):215–219. [PubMed] [Google Scholar]
  6. Agnes M., Lung K. Y., Wang J. C. Effects of prostaglandin E1 on canine nasal vascular and airway resistances. J Pharmacol Exp Ther. 1984 Jan;228(1):215–219. [PubMed] [Google Scholar]
  7. Alosachie I., Godfraind T. Role of cyclic GMP in the modulation by endothelium of the adrenolytic action of prazosin in the rat isolated aorta. Br J Pharmacol. 1986 Nov;89(3):525–532. doi: 10.1111/j.1476-5381.1986.tb11152.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Altiere R. J., Olson J. W., Gillespie M. N. Altered pulmonary vascular smooth muscle responsiveness in monocrotaline-induced pulmonary hypertension. J Pharmacol Exp Ther. 1986 Feb;236(2):390–395. [PubMed] [Google Scholar]
  9. Altura B. M., Altura B. T. Vascular smooth muscle and prostaglandins. Fed Proc. 1976 Oct;35(12):2360–2366. [PubMed] [Google Scholar]
  10. Andrews H. E., Bruckdorfer K. R., Dunn R. C., Jacobs M. Low-density lipoproteins inhibit endothelium-dependent relaxation in rabbit aorta. Nature. 1987 May 21;327(6119):237–239. doi: 10.1038/327237a0. [DOI] [PubMed] [Google Scholar]
  11. Arch J. R., Ainsworth A. T., Cawthorne M. A., Piercy V., Sennitt M. V., Thody V. E., Wilson C., Wilson S. Atypical beta-adrenoceptor on brown adipocytes as target for anti-obesity drugs. Nature. 1984 May 10;309(5964):163–165. doi: 10.1038/309163a0. [DOI] [PubMed] [Google Scholar]
  12. Arch J. R., Buckle D. R., Bumstead J., Clarke G. D., Taylor J. F., Taylor S. G. Evaluation of the potassium channel activator cromakalim (BRL 34915) as a bronchodilator in the guinea-pig: comparison with nifedipine. Br J Pharmacol. 1988 Nov;95(3):763–770. doi: 10.1111/j.1476-5381.1988.tb11702.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Armstrong R. A., Jones R. L., Peesapati V., Will S. G., Wilson N. H. Competitive antagonism at thromboxane receptors in human platelets. Br J Pharmacol. 1985 Mar;84(3):595–607. doi: 10.1111/j.1476-5381.1985.tb16139.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Arnt J., Hyttel J. Facilitation of 8-OHDPAT-induced forepaw treading of rats by the 5-HT2 agonist DOI. Eur J Pharmacol. 1989 Feb 14;161(1):45–51. doi: 10.1016/0014-2999(89)90178-7. [DOI] [PubMed] [Google Scholar]
  15. Auguet M., Delaflotte S., Chabrier P. E., Pirotzky E., Clostre F., Braquet P. Endothelin and Ca++ agonist Bay K 8644: different vasoconstrictive properties. Biochem Biophys Res Commun. 1988 Oct 14;156(1):186–192. doi: 10.1016/s0006-291x(88)80822-2. [DOI] [PubMed] [Google Scholar]
  16. Avissar S., Schreiber G., Danon A., Belmaker R. H. Lithium inhibits adrenergic and cholinergic increases in GTP binding in rat cortex. Nature. 1988 Feb 4;331(6155):440–442. doi: 10.1038/331440a0. [DOI] [PubMed] [Google Scholar]
  17. Badawy A. A., Evans M. Inhibition of rat liver tryptophan pyrrolase activity and elevation of brain tryptophan concentration by acute administration of small doses of antidepressants. Br J Pharmacol. 1982 Sep;77(1):59–67. doi: 10.1111/j.1476-5381.1982.tb09269.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Baker S. P., Boyd H. M., Potter L. T. Distribution and function of beta-adrenoceptors in different chambers of the canine heart. Br J Pharmacol. 1980 Jan;68(1):57–63. doi: 10.1111/j.1476-5381.1980.tb10698.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Baldwin B. A., Thornton S. N. Operant drinking in pigs following intracerebroventricular injections of hypertonic solutions and angiotensin II. Physiol Behav. 1986;36(2):325–328. doi: 10.1016/0031-9384(86)90024-7. [DOI] [PubMed] [Google Scholar]
  20. Ballard H. J., Cotterrell D., Karim F. Appearance of adenosine in venous blood from the contracting gracilis muscle and its role in vasodilatation in the dog. J Physiol. 1987 Jun;387:401–413. doi: 10.1113/jphysiol.1987.sp016580. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Balmforth A. J., Yasunari K., Vaughan P. F., Ball S. G. Characterization of dopamine and beta-adrenergic receptors linked to cyclic AMP formation in intact cells of the clone D384 derived from a human astrocytoma. J Neurochem. 1988 Nov;51(5):1510–1515. doi: 10.1111/j.1471-4159.1988.tb01119.x. [DOI] [PubMed] [Google Scholar]
  22. Bartrup J. T., Stone T. W. Interactions of adenosine and magnesium on rat hippocampal slices. Brain Res. 1988 Nov 1;463(2):374–379. doi: 10.1016/0006-8993(88)90413-1. [DOI] [PubMed] [Google Scholar]
  23. Bebbington A., Brimblecombe R. W., Shakeshaft D. The central and peripheral activity of acetylenic amines related to oxotremorine. Br J Pharmacol Chemother. 1966 Jan;26(1):56–67. doi: 10.1111/j.1476-5381.1966.tb01811.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Beddell C. R., Goodford P. J., Kneen G., White R. D., Wilkinson S., Wootton R. Substituted benzaldehydes designed to increase the oxygen affinity of human haemoglobin and inhibit the sickling of sickle erythrocytes. Br J Pharmacol. 1984 Jun;82(2):397–407. doi: 10.1111/j.1476-5381.1984.tb10775.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Bellemann P. Binding properties of a novel calcium channel activating dihydropyridine in monolayer cultures of beating myocytes. FEBS Lett. 1984 Feb 13;167(1):88–92. doi: 10.1016/0014-5793(84)80838-8. [DOI] [PubMed] [Google Scholar]
  26. Berenbaum M. C., Akande S. L., Bonnett R., Kaur H., Ioannou S., White R. D., Winfield U. J. meso-Tetra(hydroxyphenyl)porphyrins, a new class of potent tumour photosensitisers with favourable selectivity. Br J Cancer. 1986 Nov;54(5):717–725. doi: 10.1038/bjc.1986.232. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Beresford J. N., Gallagher J. A., Poser J. W., Russell R. G. Production of osteocalcin by human bone cells in vitro. Effects of 1,25(OH)2D3, 24,25(OH)2D3, parathyroid hormone, and glucocorticoids. Metab Bone Dis Relat Res. 1984;5(5):229–234. doi: 10.1016/0221-8747(84)90064-x. [DOI] [PubMed] [Google Scholar]
  28. Berridge M. J. Rapid accumulation of inositol trisphosphate reveals that agonists hydrolyse polyphosphoinositides instead of phosphatidylinositol. Biochem J. 1983 Jun 15;212(3):849–858. doi: 10.1042/bj2120849. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Black J. W., Leff P., Shankley N. P., Wood J. An operational model of pharmacological agonism: the effect of E/[A] curve shape on agonist dissociation constant estimation. Br J Pharmacol. 1985 Feb;84(2):561–571. doi: 10.1111/j.1476-5381.1985.tb12941.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Blackburn T. P., Thornber C. W., Pearce R. J., Cox B. In vitro studies with ICI 169,369, a chemically novel 5-HT antagonist. Eur J Pharmacol. 1988 Jun 10;150(3):247–256. doi: 10.1016/0014-2999(88)90005-2. [DOI] [PubMed] [Google Scholar]
  31. Bock M. G., DiPardo R. M., Evans B. E., Rittle K. E., Whitter W. L., Veber D. E., Anderson P. S., Freidinger R. M. Benzodiazepine gastrin and brain cholecystokinin receptor ligands: L-365,260. J Med Chem. 1989 Jan;32(1):13–16. doi: 10.1021/jm00121a004. [DOI] [PubMed] [Google Scholar]
  32. Bockman E. L., Berne R. M., Rubio R. Release of adenosine and lack of release of ATP from contracting skeletal muscle. Pflugers Arch. 1975 Mar 26;355(3):229–241. doi: 10.1007/BF00583686. [DOI] [PubMed] [Google Scholar]
  33. Bockman E. L., McKenzie J. E. Tissue adenosine content in active soleus and gracilis muscles of cats. Am J Physiol. 1983 Apr;244(4):H552–H559. doi: 10.1152/ajpheart.1983.244.4.H552. [DOI] [PubMed] [Google Scholar]
  34. Boden P., Hill R. G. Effects of cholecystokinin and related peptides on neuronal activity in the ventromedial nucleus of the rat hypothalamus. Br J Pharmacol. 1988 May;94(1):246–252. doi: 10.1111/j.1476-5381.1988.tb11521.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Bond R. A., Charlton K. G., Clarke D. E. Responses to norepinephrine resistant to inhibition by alpha and beta adrenoceptor antagonists. J Pharmacol Exp Ther. 1986 Feb;236(2):408–415. [PubMed] [Google Scholar]
  36. Bond R. A., Clarke D. E. Agonist and antagonist characterization of a putative adrenoceptor with distinct pharmacological properties from the alpha- and beta-subtypes. Br J Pharmacol. 1988 Nov;95(3):723–734. doi: 10.1111/j.1476-5381.1988.tb11698.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Bonner T. I. The molecular basis of muscarinic receptor diversity. Trends Neurosci. 1989 Apr;12(4):148–151. doi: 10.1016/0166-2236(89)90054-4. [DOI] [PubMed] [Google Scholar]
  38. Bonner T. I., Young A. C., Brann M. R., Buckley N. J. Cloning and expression of the human and rat m5 muscarinic acetylcholine receptor genes. Neuron. 1988 Jul;1(5):403–410. doi: 10.1016/0896-6273(88)90190-0. [DOI] [PubMed] [Google Scholar]
  39. Bouquet J., Noach E. L. Some aspects of the adrenergic system of the isolated rat seminal vesicle. Arch Int Pharmacodyn Ther. 1971 Feb;189(2):397–398. [PubMed] [Google Scholar]
  40. Bowman A., McGrath J. C. The effect of hypoxia on neuroeffector transmission in the bovine retractor penis and rat anococcygeus muscles. Br J Pharmacol. 1985 Aug;85(4):869–875. doi: 10.1111/j.1476-5381.1985.tb11086.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Brammer M. J., Hajimohammadreza I., Sardiwal S., Weaver K. Is inositol bisphosphate the product of A23187 and carbachol-mediated polyphosphoinositide breakdown in synaptosomes? J Neurochem. 1988 Aug;51(2):514–521. doi: 10.1111/j.1471-4159.1988.tb01068.x. [DOI] [PubMed] [Google Scholar]
  42. Brazell M. P., Marsden C. A., Nisbet A. P., Routledge C. The 5-HT1 receptor agonist RU-24969 decreases 5-hydroxytryptamine (5-HT) release and metabolism in the rat frontal cortex in vitro and in vivo. Br J Pharmacol. 1985 Sep;86(1):209–216. doi: 10.1111/j.1476-5381.1985.tb09451.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Bristow M. R., Ginsburg R., Minobe W., Cubicciotti R. S., Sageman W. S., Lurie K., Billingham M. E., Harrison D. C., Stinson E. B. Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. N Engl J Med. 1982 Jul 22;307(4):205–211. doi: 10.1056/NEJM198207223070401. [DOI] [PubMed] [Google Scholar]
  44. Brodde O. E., Anlauf M., Graben N., Bock K. D. In vitro and in vivo down-regulation of human platelet alpha 2-adrenoceptors by clonidine. Eur J Clin Pharmacol. 1982;23(5):403–409. doi: 10.1007/BF00605989. [DOI] [PubMed] [Google Scholar]
  45. Brown D. A., Caulfield M. P., Kirby P. J. Relation between catecholamine-induced cyclic AMP changes and hyperpolarization in isolated rat sympathetic ganglia. J Physiol. 1979 May;290(2):441–451. doi: 10.1113/jphysiol.1979.sp012782. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Brown E. A., Griffiths R., Harvey C. A., Owen D. A. Pharmacological studies with SK&F 93944 (temelastine), a novel histamine H1-receptor antagonist with negligible ability to penetrate the central nervous system. Br J Pharmacol. 1986 Mar;87(3):569–578. doi: 10.1111/j.1476-5381.1986.tb10199.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Bruns R. F., Fergus J. H., Badger E. W., Bristol J. A., Santay L. A., Hartman J. D., Hays S. J., Huang C. C. Binding of the A1-selective adenosine antagonist 8-cyclopentyl-1,3-dipropylxanthine to rat brain membranes. Naunyn Schmiedebergs Arch Pharmacol. 1987 Jan;335(1):59–63. doi: 10.1007/BF00165037. [DOI] [PubMed] [Google Scholar]
  48. Bruns R. F., Fergus J. H., Badger E. W., Bristol J. A., Santay L. A., Hays S. J. PD 115,199: an antagonist ligand for adenosine A2 receptors. Naunyn Schmiedebergs Arch Pharmacol. 1987 Jan;335(1):64–69. doi: 10.1007/BF00165038. [DOI] [PubMed] [Google Scholar]
  49. Burnstock G. Purinergic nerves. Pharmacol Rev. 1972 Sep;24(3):509–581. [PubMed] [Google Scholar]
  50. Burton G. W., Cheeseman K. H., Doba T., Ingold K. U., Slater T. F. Vitamin E as an antioxidant in vitro and in vivo. Ciba Found Symp. 1983;101:4–18. doi: 10.1002/9780470720820.ch2. [DOI] [PubMed] [Google Scholar]
  51. Butler A., Hill J. M., Ireland S. J., Jordan C. C., Tyers M. B. Pharmacological properties of GR38032F, a novel antagonist at 5-HT3 receptors. Br J Pharmacol. 1988 Jun;94(2):397–412. doi: 10.1111/j.1476-5381.1988.tb11542.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. COURVOISIER S., FOURNEL J., DUCROT R., KOLSKY M., KOETSCHET P. Propriétés pharmacodynamiques du chlorhydrate de chloro-3-(diméthylamino-3'-propyl)-10-phénothiazine (4,560 R.P.); étude expérimentale d'un nouveau corps utilisé dans l'anesthésie potentialisée et dans l'hibernation artificielle. Arch Int Pharmacodyn Ther. 1953 Jan;92(3-4):305–361. [PubMed] [Google Scholar]
  53. Calcutt N. A., Tomlinson D. R., Willars G. B. Ganglioside treatment of streptozotocin-diabetic rats prevents defective axonal transport of 6-phosphofructokinase activity. J Neurochem. 1988 May;50(5):1478–1483. doi: 10.1111/j.1471-4159.1988.tb03033.x. [DOI] [PubMed] [Google Scholar]
  54. Century B., Horwitt M. K. Biological availability of various forms of vitamin E with respect to different indices of deficiency. Fed Proc. 1965 Jul-Aug;24(4):906–911. [PubMed] [Google Scholar]
  55. Chandy K. G., DeCoursey T. E., Cahalan M. D., McLaughlin C., Gupta S. Voltage-gated potassium channels are required for human T lymphocyte activation. J Exp Med. 1984 Aug 1;160(2):369–385. doi: 10.1084/jem.160.2.369. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Chang R. S., Lotti V. J. Biochemical and pharmacological characterization of an extremely potent and selective nonpeptide cholecystokinin antagonist. Proc Natl Acad Sci U S A. 1986 Jul;83(13):4923–4926. doi: 10.1073/pnas.83.13.4923. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Chang R. S., Lotti V. J. Biochemical and pharmacological characterization of an extremely potent and selective nonpeptide cholecystokinin antagonist. Proc Natl Acad Sci U S A. 1986 Jul;83(13):4923–4926. doi: 10.1073/pnas.83.13.4923. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Chang R. S., Synder S. H. Histamine H1-receptor binding sites in guinea pig brain membranes: regulation of agonist interactions by guanine nucleotides and cations. J Neurochem. 1980 Apr;34(4):916–922. doi: 10.1111/j.1471-4159.1980.tb09666.x. [DOI] [PubMed] [Google Scholar]
  59. Chaouloff F., Jeanrenaud B. 5-HT1A and alpha-2 adrenergic receptors mediate the hyperglycemic and hypoinsulinemic effects of 8-hydroxy-2-(di-n-propylamino)tetralin in the conscious rat. J Pharmacol Exp Ther. 1987 Dec;243(3):1159–1166. [PubMed] [Google Scholar]
  60. Chiu A. T., Bozarth J. M., Timmermans P. B. Relationship between phosphatidylinositol turnover and Ca++ mobilization induced by alpha-1 adrenoceptor stimulation in the rat aorta. J Pharmacol Exp Ther. 1987 Jan;240(1):123–127. [PubMed] [Google Scholar]
  61. Chung B. H., Wilkinson T., Geer J. C., Segrest J. P. Preparative and quantitative isolation of plasma lipoproteins: rapid, single discontinuous density gradient ultracentrifugation in a vertical rotor. J Lipid Res. 1980 Mar;21(3):284–291. [PubMed] [Google Scholar]
  62. Clapham J. C., Wilson C. Anti-spasmogenic and spasmolytic effects of BRL 34915: a comparison with nifedipine and nicorandil. J Auton Pharmacol. 1987 Sep;7(3):233–242. doi: 10.1111/j.1474-8673.1987.tb00152.x. [DOI] [PubMed] [Google Scholar]
  63. Coleman R. A., Humphrey P. P., Kennedy I., Levy G. P., Lumley P. Comparison of the actions of U-46619, a prostaglandin H2-analogue, with those of prostaglandin H2 and thromboxane A2 on some isolated smooth muscle preparations. Br J Pharmacol. 1981 Jul;73(3):773–778. doi: 10.1111/j.1476-5381.1981.tb16814.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Cook N. S., Hof R. P. Cardiovascular effects of apamin and BRL 34915 in rats and rabbits. Br J Pharmacol. 1988 Jan;93(1):121–131. doi: 10.1111/j.1476-5381.1988.tb11412.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Cummings S. A., Kaumann A. J., Groszmann R. J. Comparison of the hemodynamic responses to ketanserin and prazosin in portal hypertensive rats. Hepatology. 1988 Sep-Oct;8(5):1112–1115. doi: 10.1002/hep.1840080523. [DOI] [PubMed] [Google Scholar]
  66. D'Amore P., Shepro D. Stimulation of growth and calcium influx in cultured, bovine, aortic endothelial cells by platelets and vasoactive substances. J Cell Physiol. 1977 Aug;92(2):177–183. doi: 10.1002/jcp.1040920206. [DOI] [PubMed] [Google Scholar]
  67. Dale M. M., Penfield A. Comparison of the effects of indomethacin, RHC80267 and R59022 on superoxide production by 1,oleoyl-2,acetyl glycerol and A23187 in human neutrophils. Br J Pharmacol. 1987 Sep;92(1):63–68. doi: 10.1111/j.1476-5381.1987.tb11296.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Dale M. M., Penfield A. Superoxide generation by either 1-oleoyl-2-acetylglycerol or A23187 in human neutrophils is enhanced by indomethacin. FEBS Lett. 1985 Jun 3;185(1):213–217. doi: 10.1016/0014-5793(85)80772-9. [DOI] [PubMed] [Google Scholar]
  69. Daly C. J., Dunn W. R., McGrath J. C., Wilson V. G. An attempt at selective protection from phenoxybenzamine of postjunctional alpha-adrenoceptor subtypes mediating contractions to noradrenaline in the rabbit isolated saphenous vein. Br J Pharmacol. 1988 Oct;95(2):501–511. doi: 10.1111/j.1476-5381.1988.tb11670.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. Daly C. J., McGrath J. C., Wilson V. G. Evidence that the population of postjunctional-adrenoceptors mediating contraction of smooth muscle in the rabbit isolated ear vein is predominantly alpha 2. Br J Pharmacol. 1988 Aug;94(4):1085–1090. doi: 10.1111/j.1476-5381.1988.tb11626.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. Daly J. W. Adenosine receptors. Adv Cyclic Nucleotide Protein Phosphorylation Res. 1985;19:29–46. [PubMed] [Google Scholar]
  72. Dascombe M. J. The pharmacology of fever. Prog Neurobiol. 1985;25(4):327–373. doi: 10.1016/0301-0082(85)90019-x. [DOI] [PubMed] [Google Scholar]
  73. De Clerck F. F., Herman A. G. 5-hydroxytryptamine and platelet aggregation. Fed Proc. 1983 Feb;42(2):228–232. [PubMed] [Google Scholar]
  74. Dean J., Schechter A. N. Sickle-cell anemia: molecular and cellular bases of therapeutic approaches (first of three parts). N Engl J Med. 1978 Oct 5;299(14):752–763. doi: 10.1056/NEJM197810052991405. [DOI] [PubMed] [Google Scholar]
  75. Dey P. K., Feldberg W. Analgesia produced by morphine when acting from the liquor space. Br J Pharmacol. 1976 Nov;58(3):383–393. doi: 10.1111/j.1476-5381.1976.tb07715.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  76. Docherty J. R. An investigation of the effects of intravenous injection of the 5-hydroxytryptamine 2 receptor antagonists ketanserin and LY 53857 on blood pressure in anesthetized spontaneously hypertensive rats. J Pharmacol Exp Ther. 1989 Feb;248(2):736–740. [PubMed] [Google Scholar]
  77. Donaldson J., Brown A. M., Hill S. J. Influence of rolipram on the cyclic 3',5'-adenosine monophosphate response to histamine and adenosine in slices of guinea-pig cerebral cortex. Biochem Pharmacol. 1988 Feb 15;37(4):715–723. doi: 10.1016/0006-2952(88)90146-3. [DOI] [PubMed] [Google Scholar]
  78. Doods H. N., Mathy M. J., Davidesko D., van Charldorp K. J., de Jonge A., van Zwieten P. A. Selectivity of muscarinic antagonists in radioligand and in vivo experiments for the putative M1, M2 and M3 receptors. J Pharmacol Exp Ther. 1987 Jul;242(1):257–262. [PubMed] [Google Scholar]
  79. Dourish C. T., Hawley D., Iversen S. D. Enhancement of morphine analgesia and prevention of morphine tolerance in the rat by the cholecystokinin antagonist L-364,718. Eur J Pharmacol. 1988 Mar 15;147(3):469–472. doi: 10.1016/0014-2999(88)90183-5. [DOI] [PubMed] [Google Scholar]
  80. Dourish C. T., Hutson P. H., Kennett G. A., Curzon G. 8-OH-DPAT-induced hyperphagia: its neural basis and possible therapeutic relevance. Appetite. 1986;7 (Suppl):127–140. doi: 10.1016/s0195-6663(86)80058-7. [DOI] [PubMed] [Google Scholar]
  81. Downing O. A., Wilson K. A., Wilson V. G. Non-competitive antagonism of the alpha-adrenoceptor-mediated fast component of contraction of rat aorta, by doxazosin and prazosin. Br J Pharmacol. 1983 Oct;80(2):315–322. doi: 10.1111/j.1476-5381.1983.tb10036.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  82. Drew G. M. Pharmacological characterization of the presynaptic alpha-adrenoceptors regulating cholinergic activity in the guinea-pig ileum. Br J Pharmacol. 1978 Oct;64(2):293–300. doi: 10.1111/j.1476-5381.1978.tb17303.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  83. Dunkley P. R., Jarvie P. E., Heath J. W., Kidd G. J., Rostas J. A. A rapid method for isolation of synaptosomes on Percoll gradients. Brain Res. 1986 Apr 30;372(1):115–129. doi: 10.1016/0006-8993(86)91464-2. [DOI] [PubMed] [Google Scholar]
  84. Dunn W. R., McGrath J. C., Wilson V. G. Expression of functional postjunctional alpha 2-adrenoceptors in rabbit isolated distal saphenous artery--a permissive role for angiotensin II? Br J Pharmacol. 1989 Feb;96(2):259–261. doi: 10.1111/j.1476-5381.1989.tb11810.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  85. Dzau V. J. Implications of local angiotensin production in cardiovascular physiology and pharmacology. Am J Cardiol. 1987 Jan 23;59(2):59A–65A. doi: 10.1016/0002-9149(87)90178-0. [DOI] [PubMed] [Google Scholar]
  86. Ervin G. N., Birkemo L. S., Nemeroff C. B., Prange A. J., Jr Neurotensin blocks certain amphetamine-induced behaviours. Nature. 1981 May 7;291(5810):73–76. doi: 10.1038/291073a0. [DOI] [PubMed] [Google Scholar]
  87. Farmer S. G., Canning B. J., Wilkins D. E. Adenosine receptor-mediated contraction and relaxation of guinea-pig isolated tracheal smooth muscle: effects of adenosine antagonists. Br J Pharmacol. 1988 Oct;95(2):371–378. doi: 10.1111/j.1476-5381.1988.tb11655.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  88. Fedan J. S., Besse J. C., Carpenter F. G., Teague R. S. Motor innervation of the smooth muscle of the rat seminal vesicle. J Pharmacol Exp Ther. 1977 May;201(2):285–297. [PubMed] [Google Scholar]
  89. Feuerstein T. J., Bammert J., Meyer D. K. Endogenous agonists may change the concentration-response curves of exogenous agonists: source of quantitative information about the endogenous tone. Biol Cybern. 1987;56(5-6):419–429. doi: 10.1007/BF00319521. [DOI] [PubMed] [Google Scholar]
  90. File S. E. What can be learned from the effects of benzodiazepines on exploratory behavior? Neurosci Biobehav Rev. 1985 Spring;9(1):45–54. doi: 10.1016/0149-7634(85)90031-4. [DOI] [PubMed] [Google Scholar]
  91. Finberg J. P., Kopin I. J. Chronic clonidine treatment produces desensitisation of post- but not presynaptic alpha 2-adrenoceptors. Eur J Pharmacol. 1987 Jun 12;138(1):95–100. doi: 10.1016/0014-2999(87)90342-6. [DOI] [PubMed] [Google Scholar]
  92. Fingar V. H., Mang T. S., Henderson B. W. Modification of photodynamic therapy-induced hypoxia by fluosol-DA (20%) and carbogen breathing in mice. Cancer Res. 1988 Jun 15;48(12):3350–3354. [PubMed] [Google Scholar]
  93. Fisher S. K., Figueiredo J. C., Bartus R. T. Differential stimulation of inositol phospholipid turnover in brain by analogs of oxotremorine. J Neurochem. 1984 Oct;43(4):1171–1179. doi: 10.1111/j.1471-4159.1984.tb12858.x. [DOI] [PubMed] [Google Scholar]
  94. Fitzharris P., McLean A. E., Sparks R. G., Weatherley B. C., White R. D., Wootton R. The effects in volunteers of BW12C, a compound designed to left-shift the blood-oxygen saturation curve. Br J Clin Pharmacol. 1985 Apr;19(4):471–481. doi: 10.1111/j.1365-2125.1985.tb02672.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  95. Fleckenstein A., Frey M., Zorn J., Fleckenstein-Grün G. Experimental basis of the long-term therapy of arterial hypertension with calcium antagonists. Am J Cardiol. 1985 Dec 6;56(16):3H–14H. doi: 10.1016/0002-9149(85)90537-5. [DOI] [PubMed] [Google Scholar]
  96. Flood J. F., Cherkin A. Scopolamine effects on memory retention in mice: a model of dementia? Behav Neural Biol. 1986 Mar;45(2):169–184. doi: 10.1016/s0163-1047(86)90750-8. [DOI] [PubMed] [Google Scholar]
  97. Fort F. L., Pratt M. C., Carter G. W., Lewkowski J. P., Heyman I. A., Cusick P. K., Kesterson J. W. Heinz bodies, methemoglobinemia, and hemolytic anemia induced in rats by 3-amino-1-[m-(trifluoromethyl)phenyl]-2-pyrazoline. Fundam Appl Toxicol. 1984 Apr;4(2 Pt 1):216–220. doi: 10.1016/0272-0590(84)90122-2. [DOI] [PubMed] [Google Scholar]
  98. Fouda A. K., Marazzi A., Boillat N., Sonnay M., Guillain H., Atkinson J. Changes in the vascular reactivity of the isolated tail arteries of spontaneous and renovascular hypertensive rats to endogenous and exogenous noradrenaline. Blood Vessels. 1987;24(1-2):63–75. doi: 10.1159/000158672. [DOI] [PubMed] [Google Scholar]
  99. Fozard J. R., Ali A. T. Receptors for 5-hydroxytryptamine on the sympathetic nerves of the rabbit heart. Naunyn Schmiedebergs Arch Pharmacol. 1978 Jan-Feb;301(3):223–235. doi: 10.1007/BF00507041. [DOI] [PubMed] [Google Scholar]
  100. Fozard J. R., Mir A. K., Middlemiss D. N. Cardiovascular response to 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) in the rat: site of action and pharmacological analysis. J Cardiovasc Pharmacol. 1987 Mar;9(3):328–347. doi: 10.1097/00005344-198703000-00010. [DOI] [PubMed] [Google Scholar]
  101. French A. M., Scott N. C. A comparison of the effects of nifedipine and verapamil on rat vas deferens. Br J Pharmacol. 1981 Jun;73(2):321–323. doi: 10.1111/j.1476-5381.1981.tb10424.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  102. Fryer A. D., Maclagan J. Pancuronium and gallamine are antagonists for pre- and post-junctional muscarinic receptors in the guinea-pig lung. Naunyn Schmiedebergs Arch Pharmacol. 1987 Apr;335(4):367–371. doi: 10.1007/BF00165549. [DOI] [PubMed] [Google Scholar]
  103. Fuchs B. D., Gorman M. W., Sparks H. V. Adenosine release into venous plasma during free flow exercise. Proc Soc Exp Biol Med. 1986 Mar;181(3):364–370. doi: 10.3181/00379727-181-42266. [DOI] [PubMed] [Google Scholar]
  104. Furchgott R. F. The role of endothelium in the responses of vascular smooth muscle to drugs. Annu Rev Pharmacol Toxicol. 1984;24:175–197. doi: 10.1146/annurev.pa.24.040184.001135. [DOI] [PubMed] [Google Scholar]
  105. Furness J. B., Costa M., Rökaeus A., McDonald T. J., Brooks B. Galanin-immunoreactive neurons in the guinea-pig small intestine: their projections and relationships to other enteric neurons. Cell Tissue Res. 1987 Dec;250(3):607–615. doi: 10.1007/BF00218954. [DOI] [PubMed] [Google Scholar]
  106. Förstermann U., Goppelt-Strübe M., Frölich J. C., Busse R. Inhibitors of acyl-coenzyme A:lysolecithin acyltransferase activate the production of endothelium-derived vascular relaxing factor. J Pharmacol Exp Ther. 1986 Jul;238(1):352–359. [PubMed] [Google Scholar]
  107. Gabbiani G., Ryan G. B., Majne G. Presence of modified fibroblasts in granulation tissue and their possible role in wound contraction. Experientia. 1971 May 15;27(5):549–550. doi: 10.1007/BF02147594. [DOI] [PubMed] [Google Scholar]
  108. Gardiner P. J. Characterization of prostanoid relaxant/inhibitory receptors (psi) using a highly selective agonist, TR4979. Br J Pharmacol. 1986 Jan;87(1):45–56. doi: 10.1111/j.1476-5381.1986.tb10155.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  109. Gardiner P. J. Characterization of prostanoid relaxant/inhibitory receptors (psi) using a highly selective agonist, TR4979. Br J Pharmacol. 1986 Jan;87(1):45–56. doi: 10.1111/j.1476-5381.1986.tb10155.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  110. Gardner C. R. Potential use of drugs modulating 5HT activity in the treatment of anxiety. Gen Pharmacol. 1988;19(3):347–356. doi: 10.1016/0306-3623(88)90027-4. [DOI] [PubMed] [Google Scholar]
  111. Garrino M. G., Schmeer W., Nenquin M., Meissner H. P., Henquin J. C. Mechanism of the stimulation of insulin release in vitro by HB 699, a benzoic acid derivative similar to the non-sulphonylurea moiety of glibenclamide. Diabetologia. 1985 Sep;28(9):697–703. doi: 10.1007/BF00291979. [DOI] [PubMed] [Google Scholar]
  112. Garthwaite J., Charles S. L., Chess-Williams R. Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain. Nature. 1988 Nov 24;336(6197):385–388. doi: 10.1038/336385a0. [DOI] [PubMed] [Google Scholar]
  113. Gent J. P., Bentley M., Feely M., Haigh J. R. Benzodiazepine cross-tolerance in mice extends to sodium valproate. Eur J Pharmacol. 1986 Aug 22;128(1-2):9–15. doi: 10.1016/0014-2999(86)90551-0. [DOI] [PubMed] [Google Scholar]
  114. Gent J. P., Feely M. P., Haigh J. R. Differences between the tolerance characteristics of two anticonvulsant benzodiazepines. Life Sci. 1985 Sep 2;37(9):849–856. doi: 10.1016/0024-3205(85)90520-x. [DOI] [PubMed] [Google Scholar]
  115. Gibbs J., Young R. C., Smith G. P. Cholecystokinin decreases food intake in rats. J Comp Physiol Psychol. 1973 Sep;84(3):488–495. doi: 10.1037/h0034870. [DOI] [PubMed] [Google Scholar]
  116. Gibson A., Mirzazadeh S. N-methylhydroxylamine inhibits and M&B 22948 potentiates relaxations of the mouse anococcygeus to non-adrenergic, non-cholinergic field stimulation and to nitrovasodilator drugs. Br J Pharmacol. 1989 Mar;96(3):637–644. doi: 10.1111/j.1476-5381.1989.tb11863.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  117. Gillespie J. S., Maclaren A., Pollock D. A method of stimulating different segments of the autonomic outflow from the spinal column to various organs in the pithed cat and rat. Br J Pharmacol. 1970 Oct;40(2):257–267. doi: 10.1111/j.1476-5381.1970.tb09919.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  118. Glennon R. A. Discriminative stimulus properties of the serotonergic agent 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI). Life Sci. 1986 Sep 1;39(9):825–830. doi: 10.1016/0024-3205(86)90461-3. [DOI] [PubMed] [Google Scholar]
  119. Glennon R. A., McKenney J. D., Lyon R. A., Titeler M. 5-HT1 and 5-HT2 binding characteristics of 1-(2,5-dimethoxy-4-bromophenyl)-2-aminopropane analogues. J Med Chem. 1986 Feb;29(2):194–199. doi: 10.1021/jm00152a005. [DOI] [PubMed] [Google Scholar]
  120. Godfrey R. W., Johnson W. J., Hoffstein S. T. Recombinant tumor necrosis factor and interleukin-1 both stimulate human synovial cell arachidonic acid release and phospholipid metabolism. Biochem Biophys Res Commun. 1987 Jan 15;142(1):235–241. doi: 10.1016/0006-291x(87)90476-1. [DOI] [PubMed] [Google Scholar]
  121. Goedert M., Pinnock R. D., Downes C. P., Mantyh P. W., Emson P. C. Neurotensin stimulates inositol phospholipid hydrolysis in rat brain slices. Brain Res. 1984 Dec 3;323(1):193–197. doi: 10.1016/0006-8993(84)90288-9. [DOI] [PubMed] [Google Scholar]
  122. Goldie R. G., Spina D., Paterson J. W. Beta agonist-induced desensitization in pig bronchus. J Pharmacol Exp Ther. 1986 Apr;237(1):275–282. [PubMed] [Google Scholar]
  123. Goodchild A. K., Moon E. A., Dampney R. A., Howe P. R. Evidence that adrenaline neurons in the rostral ventrolateral medulla have a vasopressor function. Neurosci Lett. 1984 Apr 6;45(3):267–272. doi: 10.1016/0304-3940(84)90237-4. [DOI] [PubMed] [Google Scholar]
  124. Goodford P. J. Prediction of pharmacological activity by the method of physicochemical-activity relationships. Adv Pharmacol Chemother. 1973;11:51–97. doi: 10.1016/s1054-3589(08)60456-1. [DOI] [PubMed] [Google Scholar]
  125. Grant G., Arvidsson J. Transganglionic degeneration in trigeminal primary sensory neurons. Brain Res. 1975 Sep 23;95(2-3):265–279. doi: 10.1016/0006-8993(75)90106-7. [DOI] [PubMed] [Google Scholar]
  126. Gross G., Hanft G., Rugevics C. 5-Methyl-urapidil discriminates between subtypes of the alpha 1-adrenoceptor. Eur J Pharmacol. 1988 Jul 7;151(2):333–335. doi: 10.1016/0014-2999(88)90819-9. [DOI] [PubMed] [Google Scholar]
  127. Grynkiewicz G., Poenie M., Tsien R. Y. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem. 1985 Mar 25;260(6):3440–3450. [PubMed] [Google Scholar]
  128. Hadházy P., Malomvölgyi B., Magyar K. Endogenous prostanoids and arterial contractility. Prostaglandins Leukot Essent Fatty Acids. 1988;32(3):175–185. doi: 10.1016/0952-3278(88)90169-x. [DOI] [PubMed] [Google Scholar]
  129. Hagan R. M., Hughes I. E. Effect of noradrenaline reuptake blockade on evoked tritium overflow from mouse vasa deferentia and rat cortex slices previously incubated with 3H-noradrenaline. J Auton Pharmacol. 1981 Dec;1(5):385–390. doi: 10.1111/j.1474-8673.1981.tb00077.x. [DOI] [PubMed] [Google Scholar]
  130. Hallam T. J., Rink T. J. Agonists stimulate divalent cation channels in the plasma membrane of human platelets. FEBS Lett. 1985 Jul 8;186(2):175–179. doi: 10.1016/0014-5793(85)80703-1. [DOI] [PubMed] [Google Scholar]
  131. Hallam T. J., Rink T. J. Receptor-mediated Ca2+ entry: diversity of function and mechanism. Trends Pharmacol Sci. 1989 Jan;10(1):8–10. doi: 10.1016/0165-6147(89)90092-8. [DOI] [PubMed] [Google Scholar]
  132. Hallam T. J., Rink T. J. Responses to adenosine diphosphate in human platelets loaded with the fluorescent calcium indicator quin2. J Physiol. 1985 Nov;368:131–146. doi: 10.1113/jphysiol.1985.sp015850. [DOI] [PMC free article] [PubMed] [Google Scholar]
  133. Hamilton T. C., Weir S. W., Weston A. H. Comparison of the effects of BRL 34915 and verapamil on electrical and mechanical activity in rat portal vein. Br J Pharmacol. 1986 May;88(1):103–111. doi: 10.1111/j.1476-5381.1986.tb09476.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  134. Hammer R., Berrie C. P., Birdsall N. J., Burgen A. S., Hulme E. C. Pirenzepine distinguishes between different subclasses of muscarinic receptors. Nature. 1980 Jan 3;283(5742):90–92. doi: 10.1038/283090a0. [DOI] [PubMed] [Google Scholar]
  135. Han C., Abel P. W., Minneman K. P. Alpha 1-adrenoceptor subtypes linked to different mechanisms for increasing intracellular Ca2+ in smooth muscle. Nature. 1987 Sep 24;329(6137):333–335. doi: 10.1038/329333a0. [DOI] [PubMed] [Google Scholar]
  136. Hannun Y. A., Loomis C. R., Bell R. M. Activation of protein kinase C by Triton X-100 mixed micelles containing diacylglycerol and phosphatidylserine. J Biol Chem. 1985 Aug 25;260(18):10039–10043. [PubMed] [Google Scholar]
  137. Harding S. E., Vescovo G., Kirby M., Jones S. M., Gurden J., Poole-Wilson P. A. Contractile responses of isolated adult rat and rabbit cardiac myocytes to isoproterenol and calcium. J Mol Cell Cardiol. 1988 Jul;20(7):635–647. doi: 10.1016/s0022-2828(88)80121-4. [DOI] [PubMed] [Google Scholar]
  138. Harms H. H., Zaagsma J., de Vente J. Differentiation of beta-adrenoceptors in right atrium, diaphragm and adipose tissue of the rat, using stereoisomers of propranolol, alprenolol, nifenalol and practolol. Life Sci. 1977 Jul 1;21(1):123–128. doi: 10.1016/0024-3205(77)90432-5. [DOI] [PubMed] [Google Scholar]
  139. Haywood J. R., Shaffer R. A., Fastenow C., Fink G. D., Brody M. J. Regional blood flow measurement with pulsed Doppler flowmeter in conscious rat. Am J Physiol. 1981 Aug;241(2):H273–H278. doi: 10.1152/ajpheart.1981.241.2.H273. [DOI] [PubMed] [Google Scholar]
  140. Haywood J. R., Shaffer R. A., Fastenow C., Fink G. D., Brody M. J. Regional blood flow measurement with pulsed Doppler flowmeter in conscious rat. Am J Physiol. 1981 Aug;241(2):H273–H278. doi: 10.1152/ajpheart.1981.241.2.H273. [DOI] [PubMed] [Google Scholar]
  141. Hendry I. A., Iversen L. L. Effect of nerve growth factor and its antiserum on tyrosine hydroxylase activity in mouse superior cervical sympathetic ganglion. Brain Res. 1971 Jun 4;29(1):159–162. doi: 10.1016/0006-8993(71)90429-x. [DOI] [PubMed] [Google Scholar]
  142. Herbert V., Lau K. S., Gottlieb C. W., Bleicher S. J. Coated charcoal immunoassay of insulin. J Clin Endocrinol Metab. 1965 Oct;25(10):1375–1384. doi: 10.1210/jcem-25-10-1375. [DOI] [PubMed] [Google Scholar]
  143. Hewson G., Leighton G. E., Hill R. G., Hughes J. The cholecystokinin receptor antagonist L364,718 increases food intake in the rat by attenuation of the action of endogenous cholecystokinin. Br J Pharmacol. 1988 Jan;93(1):79–84. doi: 10.1111/j.1476-5381.1988.tb11407.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  144. Howard M. J., Mullen M. D., Insel P. A. Amiloride interacts with renal alpha- and beta-adrenergic receptors. Am J Physiol. 1987 Jul;253(1 Pt 2):F21–F25. doi: 10.1152/ajprenal.1987.253.1.F21. [DOI] [PubMed] [Google Scholar]
  145. Hoyer D., Engel G., Kalkman H. O. Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (-)[125I]iodocyanopindolol, [3H]mesulergine and [3H]ketanserin. Eur J Pharmacol. 1985 Nov 26;118(1-2):13–23. doi: 10.1016/0014-2999(85)90658-2. [DOI] [PubMed] [Google Scholar]
  146. Hoyer D. Molecular pharmacology and biology of 5-HT1C receptors. Trends Pharmacol Sci. 1988 Mar;9(3):89–94. doi: 10.1016/0165-6147(88)90174-5. [DOI] [PubMed] [Google Scholar]
  147. Hoyer D. Molecular pharmacology and biology of 5-HT1C receptors. Trends Pharmacol Sci. 1988 Mar;9(3):89–94. doi: 10.1016/0165-6147(88)90174-5. [DOI] [PubMed] [Google Scholar]
  148. Humphrey P. P., Feniuk W., Perren M. J., Connor H. E., Oxford A. W., Coates L. H., Butina D. GR43175, a selective agonist for the 5-HT1-like receptor in dog isolated saphenous vein. Br J Pharmacol. 1988 Aug;94(4):1123–1132. doi: 10.1111/j.1476-5381.1988.tb11630.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  149. Humphrey P. P., Feniuk W., Perren M. J., Connor H. E., Oxford A. W., Coates L. H., Butina D. GR43175, a selective agonist for the 5-HT1-like receptor in dog isolated saphenous vein. Br J Pharmacol. 1988 Aug;94(4):1123–1132. doi: 10.1111/j.1476-5381.1988.tb11630.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  150. Hutson P. H., Dourish C. T., Curzon G. Evidence that the hyperphagic response to 8-OH-DPAT is mediated by 5-HT1A receptors. Eur J Pharmacol. 1988 Jun 10;150(3):361–366. doi: 10.1016/0014-2999(88)90019-2. [DOI] [PubMed] [Google Scholar]
  151. Huttenlocher P. R. Ketonemia and seizures: metabolic and anticonvulsant effects of two ketogenic diets in childhood epilepsy. Pediatr Res. 1976 May;10(5):536–540. doi: 10.1203/00006450-197605000-00006. [DOI] [PubMed] [Google Scholar]
  152. Ives N., King J. W., Chernow B., Roth B. L. BAY k 8644, a calcium channel agonist, reverses hypotension in endotoxin-shocked rats. Eur J Pharmacol. 1986 Nov 4;130(3):169–175. doi: 10.1016/0014-2999(86)90265-7. [DOI] [PubMed] [Google Scholar]
  153. Jeremy J. Y., Dandona P. Effect of endothelium removal on stimulatory and inhibitory modulation of rat aortic prostacyclin synthesis. Br J Pharmacol. 1989 Jan;96(1):243–250. doi: 10.1111/j.1476-5381.1989.tb11806.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  154. Jeremy J. Y., Mikhailidis D. P., Dandona P. The effect of nifedipine, nimodipine and nisoldipine on agonist- and trauma-stimulated vascular prostacyclin synthesis in vitro. Naunyn Schmiedebergs Arch Pharmacol. 1986 Jan;332(1):70–73. doi: 10.1007/BF00633200. [DOI] [PubMed] [Google Scholar]
  155. Jeremy J. Y., Mikhailidis D. P., Dandona P. The effect of tiaprofenic acid and indomethacin on in vitro prostaglandin synthesis by rat, rabbit and human stomach tissue. Agents Actions. 1985 Dec;17(2):205–208. doi: 10.1007/BF01966593. [DOI] [PubMed] [Google Scholar]
  156. Jeremy J. Y., Mikhailidis D. P., Thompson C. S., Barradas M. A., Dandona P. Platelet thromboxane A2 synthesizing capacity is enhanced by fasting but diminished by diabetes mellitus in the rat. Diabetes Res. 1988 Aug;8(4):177–181. [PubMed] [Google Scholar]
  157. Johnston H., Majewski H., Musgrave I. F. Involvement of cyclic nucleotides in prejunctional modulation of noradrenaline release in mouse atria. Br J Pharmacol. 1987 Aug;91(4):773–781. doi: 10.1111/j.1476-5381.1987.tb11275.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  158. Jolicoeur F. B., De Michele G., Barbeau A., St-Pierre S. Neurotensin affects hyperactivity but not stereotypy induced by pre and post synaptic dopaminergic stimulation. Neurosci Biobehav Rev. 1983 Fall;7(3):385–390. doi: 10.1016/0149-7634(83)90043-x. [DOI] [PubMed] [Google Scholar]
  159. Jones B. J., Costall B., Domeney A. M., Kelly M. E., Naylor R. J., Oakley N. R., Tyers M. B. The potential anxiolytic activity of GR38032F, a 5-HT3-receptor antagonist. Br J Pharmacol. 1988 Apr;93(4):985–993. doi: 10.1111/j.1476-5381.1988.tb11489.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  160. Kasakov L., Burnstock G. The use of the slowly degradable analog, alpha, beta-methylene ATP, to produce desensitisation of the P2-purinoceptor: effect on non-adrenergic, non-cholinergic responses of the guinea-pig urinary bladder. Eur J Pharmacol. 1982 Dec 24;86(2):291–294. doi: 10.1016/0014-2999(82)90330-2. [DOI] [PubMed] [Google Scholar]
  161. Kato R., Onoda K. Studies on the regulation of the activity of drug oxidation in rat liver microsomes by androgen and estrogen. Biochem Pharmacol. 1970 May;19(5):1649–1660. doi: 10.1016/0006-2952(70)90154-1. [DOI] [PubMed] [Google Scholar]
  162. Kaumann A. J., Birnbaumer L. Desensitization of kitten atria to chronotropic, inotropic and adenylyl cyclase stimulating effects of (-)isoprenaline. Naunyn Schmiedebergs Arch Pharmacol. 1976 May;293(2):199–202. doi: 10.1007/BF00499230. [DOI] [PubMed] [Google Scholar]
  163. Kaumann A. J. Two classes of myocardial 5-hydroxytryptamine receptors that are neither 5-HT1 nor 5-HT2. J Cardiovasc Pharmacol. 1985;7 (Suppl 7):S76–S78. doi: 10.1097/00005344-198500077-00022. [DOI] [PubMed] [Google Scholar]
  164. Kelly E., Batty I., Nahorski S. R. Dopamine receptor stimulation does not affect phosphoinositide hydrolysis in slices of rat striatum. J Neurochem. 1988 Sep;51(3):918–924. doi: 10.1111/j.1471-4159.1988.tb01828.x. [DOI] [PubMed] [Google Scholar]
  165. Kelly M. J. alpha-Tocopherol as agonist in hypoxia. J Pharm Pharmacol. 1986 Jan;38(1):66–68. doi: 10.1111/j.2042-7158.1986.tb04471.x. [DOI] [PubMed] [Google Scholar]
  166. Khokher M. A., Dandona P. The effect of indomethacin and aspirin on alkaline phosphatase secretion and [3H]thymidine incorporation by human osteoblasts. Br J Rheumatol. 1988 Aug;27(4):291–294. doi: 10.1093/rheumatology/27.4.291. [DOI] [PubMed] [Google Scholar]
  167. Kilpatrick G. J., Jones B. J., Tyers M. B. The distribution of specific binding of the 5-HT3 receptor ligand [3H]GR65630 in rat brain using quantitative autoradiography. Neurosci Lett. 1988 Nov 22;94(1-2):156–160. doi: 10.1016/0304-3940(88)90287-x. [DOI] [PubMed] [Google Scholar]
  168. Koshikawa N., Durcan M. J., Weaver K., Lawrence K., Campbell I. C. Subcellular distribution of beta-adrenoceptors in brain following administration of antidepressant drugs. Neuropharmacology. 1987 Sep;26(9):1343–1349. doi: 10.1016/0028-3908(87)90097-9. [DOI] [PubMed] [Google Scholar]
  169. Lambrecht G., Feifel R., Forth B., Strohmann C., Tacke R., Mutschler E. p-fluoro-hexahydro-sila-difenidol: the first M2 beta-selective muscarinic antagonist. Eur J Pharmacol. 1988 Jul 26;152(1-2):193–194. doi: 10.1016/0014-2999(88)90856-4. [DOI] [PubMed] [Google Scholar]
  170. Lee M. R. Dopamine and the kidney. Clin Sci (Lond) 1982 May;62(5):439–448. doi: 10.1042/cs0620439. [DOI] [PubMed] [Google Scholar]
  171. Leff P., Martin G. R. The classification of 5-hydroxytryptamine receptors. Med Res Rev. 1988 Apr-Jun;8(2):187–202. doi: 10.1002/med.2610080203. [DOI] [PubMed] [Google Scholar]
  172. Lerner P., Nosé P., Ames M. M., Lovenberg W. Modification of the tyrosine hydroxylase assay. Increased enzyme activity in the presence of ascorbic acid. Neurochem Res. 1978 Oct;3(5):641–651. doi: 10.1007/BF00963765. [DOI] [PubMed] [Google Scholar]
  173. Levine J. D., Coderre T. J., Helms C., Basbaum A. I. Beta 2-adrenergic mechanisms in experimental arthritis. Proc Natl Acad Sci U S A. 1988 Jun;85(12):4553–4556. doi: 10.1073/pnas.85.12.4553. [DOI] [PMC free article] [PubMed] [Google Scholar]
  174. Lewis R. S., Cahalan M. D. The plasticity of ion channels: parallels between the nervous and immune systems. Trends Neurosci. 1988 May;11(5):214–218. doi: 10.1016/0166-2236(88)90129-4. [DOI] [PubMed] [Google Scholar]
  175. Leysen J. E., Van Gompel P., Gommeren W., Woestenborghs R., Janssen P. A. Down regulation of serotonin-S2 receptor sites in rat brain by chronic treatment with the serotonin-S2 antagonists: ritanserin and setoperone. Psychopharmacology (Berl) 1986;88(4):434–444. doi: 10.1007/BF00178504. [DOI] [PubMed] [Google Scholar]
  176. Lin J. J., Churchill P. C., Bidani A. K. Effect of theophylline on the initiation phase of postischemic acute renal failure in rats. J Lab Clin Med. 1986 Aug;108(2):150–154. [PubMed] [Google Scholar]
  177. Lipper S., Kahn L. B., Reddick R. L. The myofibroblast. Pathol Annu. 1980;15(Pt 1):409–441. [PubMed] [Google Scholar]
  178. Little H. J., Nutt D. J., Taylor S. C. Bidirectional effects of chronic treatment with agonists and inverse agonists at the benzodiazepine receptor. Brain Res Bull. 1987 Sep;19(3):371–378. doi: 10.1016/0361-9230(87)90106-7. [DOI] [PubMed] [Google Scholar]
  179. Lotti V. J., Chang R. S. A new potent and selective non-peptide gastrin antagonist and brain cholecystokinin receptor (CCK-B) ligand: L-365,260. Eur J Pharmacol. 1989 Mar 21;162(2):273–280. doi: 10.1016/0014-2999(89)90290-2. [DOI] [PubMed] [Google Scholar]
  180. Lotti V. J., Chang R. S. A new potent and selective non-peptide gastrin antagonist and brain cholecystokinin receptor (CCK-B) ligand: L-365,260. Eur J Pharmacol. 1989 Mar 21;162(2):273–280. doi: 10.1016/0014-2999(89)90290-2. [DOI] [PubMed] [Google Scholar]
  181. Loubatières A., Mariani M. M., Ribes G., de Malbosc H., Chapal J. Etude expérimentale d'un nouveau sulfamide hypoglycémiant particulièrement actif, le HB 419 ou glibenclamide. Diabetologia. 1969 Feb;5(1):1–10. doi: 10.1007/BF01212212. [DOI] [PubMed] [Google Scholar]
  182. Lowe K. C. Perfluorocarbons as oxygen-transport fluids. Comp Biochem Physiol A Comp Physiol. 1987;87(4):825–838. doi: 10.1016/0300-9629(87)90001-6. [DOI] [PubMed] [Google Scholar]
  183. Lowe K. C. Perfluorocarbons as oxygen-transport fluids. Comp Biochem Physiol A Comp Physiol. 1987;87(4):825–838. doi: 10.1016/0300-9629(87)90001-6. [DOI] [PubMed] [Google Scholar]
  184. Lukey P. T., Anderson R., Dippenaar U. H. Benoxaprofen activates membrane-associated oxidative metabolism in human polymorphonuclear leucocytes by apparent modulation of protein kinase C. Br J Pharmacol. 1988 Feb;93(2):289–294. doi: 10.1111/j.1476-5381.1988.tb11433.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  185. Lunec J., Blake D. R., McCleary S. J., Brailsford S., Bacon P. A. Self-perpetuating mechanisms of immunoglobulin G aggregation in rheumatoid inflammation. J Clin Invest. 1985 Dec;76(6):2084–2090. doi: 10.1172/JCI112212. [DOI] [PMC free article] [PubMed] [Google Scholar]
  186. MacLennan S. J., McGrath J. C., Whittle M. J. Inhibition of the oxygen-induced contraction of the isolated human umbilical artery by indomethacin, flurbiprofen, aspirin and drugs modifying Ca2+ disposition. Prostaglandins. 1988 Nov;36(5):711–729. doi: 10.1016/0090-6980(88)90015-9. [DOI] [PubMed] [Google Scholar]
  187. Mackay D. Continuous variation of agonist affinity constants. Trends Pharmacol Sci. 1988 May;9(5):156–157. doi: 10.1016/0165-6147(88)90026-0. [DOI] [PubMed] [Google Scholar]
  188. Mais D. E., Saussy D. L., Jr, Chaikhouni A., Kochel P. J., Knapp D. R., Hamanaka N., Halushka P. V. Pharmacologic characterization of human and canine thromboxane A2/prostaglandin H2 receptors in platelets and blood vessels: evidence for different receptors. J Pharmacol Exp Ther. 1985 May;233(2):418–424. [PubMed] [Google Scholar]
  189. Maloteaux J. M., Haiech J., De Campeneere D., Berta P., Vidal N. Biochemical and physiological evidences for antiserotonergic properties of naftidrofuryl. Arzneimittelforschung. 1986 Aug;36(8):1194–1198. [PubMed] [Google Scholar]
  190. Mann J. F., Jakobs K. H., Riedel J., Ritz E. Reduced chronotropic responsiveness of the heart in experimental uremia. Am J Physiol. 1986 May;250(5 Pt 2):H846–H852. doi: 10.1152/ajpheart.1986.250.5.H846. [DOI] [PubMed] [Google Scholar]
  191. Markstein R., Hoyer D., Engel G. 5-HT1A-receptors mediate stimulation of adenylate cyclase in rat hippocampus. Naunyn Schmiedebergs Arch Pharmacol. 1986 Aug;333(4):335–341. doi: 10.1007/BF00500006. [DOI] [PubMed] [Google Scholar]
  192. Marsh S. J., Stansfeld C. E., Brown D. A., Davey R., McCarthy D. The mechanism of action of capsaicin on sensory C-type neurons and their axons in vitro. Neuroscience. 1987 Oct;23(1):275–289. doi: 10.1016/0306-4522(87)90289-2. [DOI] [PubMed] [Google Scholar]
  193. Martin G. R., Leff P., Cambridge D., Barrett V. J. Comparative analysis of two types of 5-hydroxytryptamine receptor mediating vasorelaxation: differential classification using tryptamines. Naunyn Schmiedebergs Arch Pharmacol. 1987 Oct;336(4):365–373. doi: 10.1007/BF00164867. [DOI] [PubMed] [Google Scholar]
  194. Martin K. F., Marsden C. A. In vivo voltammetry in the suprachiasmatic nucleus of the rat: effects of RU24969, methiothepin and ketanserin. Eur J Pharmacol. 1986 Feb 11;121(1):135–139. doi: 10.1016/0014-2999(86)90403-6. [DOI] [PubMed] [Google Scholar]
  195. Mastrangelo D., Mathison R., Huggel H. J., Dion S., D'Orléans-Juste P., Rhaleb N. E., Drapeau G., Rovero P., Regoli D. The rat isolated portal vein: a preparation sensitive to neurokinins, particularly neurokinin B. Eur J Pharmacol. 1987 Feb 24;134(3):321–326. doi: 10.1016/0014-2999(87)90363-3. [DOI] [PubMed] [Google Scholar]
  196. McCall R. B. Effects of putative neurotransmitters on sympathetic preganglionic neurons. Annu Rev Physiol. 1988;50:553–564. doi: 10.1146/annurev.ph.50.030188.003005. [DOI] [PubMed] [Google Scholar]
  197. McCall R. B., Harris L. T. 5-HT2 receptor agonists increase spontaneous sympathetic nerve discharge. Eur J Pharmacol. 1988 Jun 22;151(1):113–116. doi: 10.1016/0014-2999(88)90698-x. [DOI] [PubMed] [Google Scholar]
  198. McCarthy K. D., de Vellis J. The regulation of adenosine 3':5'-cyclic monophosphate accumulation in glia by alpha-adrenergic agonists. Life Sci. 1979 Feb 12;24(7):639–649. doi: 10.1016/0024-3205(79)90163-2. [DOI] [PubMed] [Google Scholar]
  199. McGrath J. C., MacLennan S. J., Mann A. C., Stuart-Smith K., Whittle M. J. Contraction of human umbilical artery, but not vein, by oxygen. J Physiol. 1986 Nov;380:513–519. doi: 10.1113/jphysiol.1986.sp016299. [DOI] [PMC free article] [PubMed] [Google Scholar]
  200. Melander T., Hökfelt T., Rökaeus A., Fahrenkrug J., Tatemoto K., Mutt V. Distribution of galanin-like immunoreactivity in the gastro-intestinal tract of several mammalian species. Cell Tissue Res. 1985;239(2):253–270. doi: 10.1007/BF00218003. [DOI] [PubMed] [Google Scholar]
  201. Meldrum L. A., Burnstock G. Evidence that ATP acts as a co-transmitter with noradrenaline in sympathetic nerves supplying the guinea-pig vas deferens. Eur J Pharmacol. 1983 Aug 19;92(1-2):161–163. doi: 10.1016/0014-2999(83)90126-7. [DOI] [PubMed] [Google Scholar]
  202. Meldrum L. A., Burnstock G. Evidence that ATP is involved as a co-transmitter in the hypogastric nerve supplying the seminal vesicle of the guinea-pig. Eur J Pharmacol. 1985 Apr 16;110(3):363–366. doi: 10.1016/0014-2999(85)90565-5. [DOI] [PubMed] [Google Scholar]
  203. Mellerup E. T., Plenge P. Imipramine binding in depression and other psychiatric conditions. Acta Psychiatr Scand Suppl. 1988;345:61–68. doi: 10.1111/j.1600-0447.1988.tb08569.x. [DOI] [PubMed] [Google Scholar]
  204. Mellerup E. T., Plenge P., Nielsen M. Size determination of binding polymers for [3H]imipramine and [3H]paroxetine in human platelet membranes. Eur J Pharmacol. 1984 Nov 13;106(2):411–413. doi: 10.1016/0014-2999(84)90730-1. [DOI] [PubMed] [Google Scholar]
  205. Miczek K. A., Thompson M. L., Shuster L. Analgesia following defeat in an aggressive encounter: development of tolerance and changes in opioid receptors. Ann N Y Acad Sci. 1986;467:14–29. doi: 10.1111/j.1749-6632.1986.tb14615.x. [DOI] [PubMed] [Google Scholar]
  206. Middlemiss D. N., Fozard J. R. 8-Hydroxy-2-(di-n-propylamino)-tetralin discriminates between subtypes of the 5-HT1 recognition site. Eur J Pharmacol. 1983 May 20;90(1):151–153. doi: 10.1016/0014-2999(83)90230-3. [DOI] [PubMed] [Google Scholar]
  207. Mihaly G. W., Ching M. S., Klejn M. B., Paull J., Smallwood R. A. Differences in the binding of quinine and quinidine to plasma proteins. Br J Clin Pharmacol. 1987 Dec;24(6):769–774. doi: 10.1111/j.1365-2125.1987.tb03244.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  208. Mikhailidis D. P., Jeremy J. Y., Barradas M. A., Green N., Dandona P. Effect of ethanol on vascular prostacyclin (prostaglandin I2) synthesis, platelet aggregation, and platelet thromboxane release. Br Med J (Clin Res Ed) 1983 Nov 19;287(6404):1495–1498. doi: 10.1136/bmj.287.6404.1495. [DOI] [PMC free article] [PubMed] [Google Scholar]
  209. Minneman K. P., Han C., Abel P. W. Comparison of alpha 1-adrenergic receptor subtypes distinguished by chlorethylclonidine and WB 4101. Mol Pharmacol. 1988 May;33(5):509–514. [PubMed] [Google Scholar]
  210. Mitchell M. R., Powell T., Terrar D. A., Twist V. W. Calcium-activated inward current and contraction in rat and guinea-pig ventricular myocytes. J Physiol. 1987 Oct;391:545–560. doi: 10.1113/jphysiol.1987.sp016755. [DOI] [PMC free article] [PubMed] [Google Scholar]
  211. Mitchell M. R., Powell T., Terrar D. A., Twist V. W. Electrical activity and contraction in cells isolated from rat and guinea-pig ventricular muscle: a comparative study. J Physiol. 1987 Oct;391:527–544. doi: 10.1113/jphysiol.1987.sp016754. [DOI] [PMC free article] [PubMed] [Google Scholar]
  212. Moilanen E., Alanko J., Seppälä E., Vapaatalo H. Effects of antirheumatic drugs on leukotriene B4 and prostanoid synthesis in human polymorphonuclear leukocytes in vitro. Agents Actions. 1988 Jul;24(3-4):387–394. doi: 10.1007/BF02028298. [DOI] [PubMed] [Google Scholar]
  213. Moran T. H., Robinson P. H., Goldrich M. S., McHugh P. R. Two brain cholecystokinin receptors: implications for behavioral actions. Brain Res. 1986 Jan 1;362(1):175–179. doi: 10.1016/0006-8993(86)91413-7. [DOI] [PubMed] [Google Scholar]
  214. Morley J. E. Neuropeptide regulation of appetite and weight. Endocr Rev. 1987 Aug;8(3):256–287. doi: 10.1210/edrv-8-3-256. [DOI] [PubMed] [Google Scholar]
  215. Morrow A. L., Creese I. Characterization of alpha 1-adrenergic receptor subtypes in rat brain: a reevaluation of [3H]WB4104 and [3H]prazosin binding. Mol Pharmacol. 1986 Apr;29(4):321–330. [PubMed] [Google Scholar]
  216. Morrow A. L., Creese I. Characterization of alpha 1-adrenergic receptor subtypes in rat brain: a reevaluation of [3H]WB4104 and [3H]prazosin binding. Mol Pharmacol. 1986 Apr;29(4):321–330. [PubMed] [Google Scholar]
  217. Morrow A. L., Creese I. Characterization of alpha 1-adrenergic receptor subtypes in rat brain: a reevaluation of [3H]WB4104 and [3H]prazosin binding. Mol Pharmacol. 1986 Apr;29(4):321–330. [PubMed] [Google Scholar]
  218. Muid R. E., Penfield A., Dale M. M. The diacylglycerol kinase inhibitor, R59022, enhances the superoxide generation from human neutrophils induced by stimulation of fMet-Leu-Phe, IgG and C3b receptors. Biochem Biophys Res Commun. 1987 Mar 13;143(2):630–637. doi: 10.1016/0006-291x(87)91400-8. [DOI] [PubMed] [Google Scholar]
  219. Neill J. C., Cooper S. J. Evidence that d-fenfluramine anorexia is mediated by 5-HT1 receptors. Psychopharmacology (Berl) 1989;97(2):213–218. doi: 10.1007/BF00442252. [DOI] [PubMed] [Google Scholar]
  220. Nicklas W. J., Vyas I., Heikkila R. E. Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine. Life Sci. 1985 Jul 1;36(26):2503–2508. doi: 10.1016/0024-3205(85)90146-8. [DOI] [PubMed] [Google Scholar]
  221. Nielsen M., Braestrup C., Squires R. F. Evidence for a late evolutionary appearance of brain-specific benzodiazepine receptors: an investigation of 18 vertebrate and 5 invertebrate species. Brain Res. 1978 Feb 10;141(2):342–346. doi: 10.1016/0006-8993(78)90203-2. [DOI] [PubMed] [Google Scholar]
  222. Nutt J. G., Woodward W. R., Hammerstad J. P., Carter J. H., Anderson J. L. The "on-off" phenomenon in Parkinson's disease. Relation to levodopa absorption and transport. N Engl J Med. 1984 Feb 23;310(8):483–488. doi: 10.1056/NEJM198402233100802. [DOI] [PubMed] [Google Scholar]
  223. O'Flynn K., Linch D. C., Tatham P. E. The effect of mitogenic lectins and monoclonal antibodies on intracellular free calcium concentration in human T-lymphocytes. Biochem J. 1984 Apr 15;219(2):661–666. doi: 10.1042/bj2190661. [DOI] [PMC free article] [PubMed] [Google Scholar]
  224. O'Neill M. F., Dourish C. T., Iversen S. D. Morphine-induced analgesia in the rat paw pressure test is blocked by CCK and enhanced by the CCK antagonist MK-329. Neuropharmacology. 1989 Mar;28(3):243–247. doi: 10.1016/0028-3908(89)90099-3. [DOI] [PubMed] [Google Scholar]
  225. O'Rourke S. T., Vanhoutte P. M. Subtypes of muscarinic receptors on adrenergic nerves and vascular smooth muscle of the canine saphenous vein. J Pharmacol Exp Ther. 1987 Apr;241(1):64–67. [PubMed] [Google Scholar]
  226. OMURA T., SATO R. THE CARBON MONOXIDE-BINDING PIGMENT OF LIVER MICROSOMES. I. EVIDENCE FOR ITS HEMOPROTEIN NATURE. J Biol Chem. 1964 Jul;239:2370–2378. [PubMed] [Google Scholar]
  227. Oberg P. A. Magnetic stimulation of nerve tissue. Med Biol Eng. 1973 Jan;11(1):55–64. doi: 10.1007/BF02477296. [DOI] [PubMed] [Google Scholar]
  228. Ogren S. O., Fuxe K., Archer T., Hall H., Holm A. C., Köhler C. Studies on the role of central 5-HT neurons in avoidance learning: a behavioral and biochemical analysis. Adv Exp Med Biol. 1981;133:681–705. doi: 10.1007/978-1-4684-3860-4_37. [DOI] [PubMed] [Google Scholar]
  229. Olesen S. P., Clapham D. E., Davies P. F. Haemodynamic shear stress activates a K+ current in vascular endothelial cells. Nature. 1988 Jan 14;331(6152):168–170. doi: 10.1038/331168a0. [DOI] [PubMed] [Google Scholar]
  230. Olivera B. M., McIntosh J. M., Cruz L. J., Luque F. A., Gray W. R. Purification and sequence of a presynaptic peptide toxin from Conus geographus venom. Biochemistry. 1984 Oct 23;23(22):5087–5090. doi: 10.1021/bi00317a001. [DOI] [PubMed] [Google Scholar]
  231. Omini C., Abbracchio M. P., Coen E., Daffonchio L., Fano M., Cattabeni F. Involvement of arachidonic acid metabolites in beta-adrenoceptor desensitization: functional and biochemical studies. Eur J Pharmacol. 1984 Nov 27;106(3):601–606. doi: 10.1016/0014-2999(84)90064-5. [DOI] [PubMed] [Google Scholar]
  232. Palmer R. M., Ashton D. S., Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature. 1988 Jun 16;333(6174):664–666. doi: 10.1038/333664a0. [DOI] [PubMed] [Google Scholar]
  233. Palmer R. M., Ferrige A. G., Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 1987 Jun 11;327(6122):524–526. doi: 10.1038/327524a0. [DOI] [PubMed] [Google Scholar]
  234. Palmer R. M., Rees D. D., Ashton D. S., Moncada S. L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation. Biochem Biophys Res Commun. 1988 Jun 30;153(3):1251–1256. doi: 10.1016/s0006-291x(88)81362-7. [DOI] [PubMed] [Google Scholar]
  235. Palmer R. M., Rees D. D., Ashton D. S., Moncada S. L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation. Biochem Biophys Res Commun. 1988 Jun 30;153(3):1251–1256. doi: 10.1016/s0006-291x(88)81362-7. [DOI] [PubMed] [Google Scholar]
  236. Parthasarathy S., Steinbrecher U. P., Barnett J., Witztum J. L., Steinberg D. Essential role of phospholipase A2 activity in endothelial cell-induced modification of low density lipoprotein. Proc Natl Acad Sci U S A. 1985 May;82(9):3000–3004. doi: 10.1073/pnas.82.9.3000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  237. Paton D. M. Structure-activity relations for presynaptic inhibition of noradrenergic and cholinergic transmission by adenosine: evidence for action on A1 receptors. J Auton Pharmacol. 1981 Sep;1(4):287–290. doi: 10.1111/j.1474-8673.1981.tb00457.x. [DOI] [PubMed] [Google Scholar]
  238. Pentikäinen P. J., Neuvonen P. J., Backman C. Human pharmacokinetics of tolfenamic acid, a new anti-inflammatory agent. Eur J Clin Pharmacol. 1981;19(5):359–365. doi: 10.1007/BF00544587. [DOI] [PubMed] [Google Scholar]
  239. Peters J. R., Grahame-Smith D. G. Human platelet 5HT receptors: characterisation and functional association. Eur J Pharmacol. 1980 Dec 5;68(3):243–256. doi: 10.1016/0014-2999(80)90522-1. [DOI] [PubMed] [Google Scholar]
  240. Pletscher A., Laubscher A. Blood platelets as models for neurons: uses and limitations. J Neural Transm Suppl. 1980;(16):7–16. doi: 10.1007/978-3-7091-8582-7_2. [DOI] [PubMed] [Google Scholar]
  241. Pollenz R. S., McCarthy K. D. Analysis of cyclic AMP-dependent changes in intermediate filament protein phosphorylation and cell morphology in cultured astroglia. J Neurochem. 1986 Jul;47(1):9–17. doi: 10.1111/j.1471-4159.1986.tb02824.x. [DOI] [PubMed] [Google Scholar]
  242. Polster P., Broekhuysen J. The adrenergic antagonism of amiodarone. Biochem Pharmacol. 1976 Jan 15;25(2):131–134. doi: 10.1016/0006-2952(76)90279-3. [DOI] [PubMed] [Google Scholar]
  243. Powell T., Terrar D. A., Twist V. W. Electrical properties of individual cells isolated from adult rat ventricular myocardium. J Physiol. 1980 May;302:131–153. doi: 10.1113/jphysiol.1980.sp013234. [DOI] [PMC free article] [PubMed] [Google Scholar]
  244. Pratt J. A., Jenner P., Johnson A. L., Shorvon S. D., Reynolds E. H. Anticonvulsant drugs alter plasma tryptophan concentrations in epileptic patients: implications for antiepileptic action and mental function. J Neurol Neurosurg Psychiatry. 1984 Oct;47(10):1131–1133. doi: 10.1136/jnnp.47.10.1131. [DOI] [PMC free article] [PubMed] [Google Scholar]
  245. Quilley J., McGiff J. C., Nasjletti A. Role of endoperoxides in arachidonic acid-induced vasoconstriction in the isolated perfused kidney of the rat. Br J Pharmacol. 1989 Jan;96(1):111–116. doi: 10.1111/j.1476-5381.1989.tb11790.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  246. Ramage A. G. Examination of the effects of some 5-HT2 receptor antagonists on central sympathetic outflow and blood pressure in anaesthetised cats. Naunyn Schmiedebergs Arch Pharmacol. 1988 Dec;338(6):601–607. doi: 10.1007/BF00165623. [DOI] [PubMed] [Google Scholar]
  247. Ramage A. G., Fozard J. R. Evidence that the putative 5-HT1A receptor agonists, 8-OH-DPAT and ipsapirone, have a central hypotensive action that differs from that of clonidine in anaesthetised cats. Eur J Pharmacol. 1987 Jun 19;138(2):179–191. doi: 10.1016/0014-2999(87)90431-6. [DOI] [PubMed] [Google Scholar]
  248. Ramage A. G., Wouters W., Bevan P. Evidence that the novel antihypertensive agent, flesinoxan, causes differential sympathoinhibition and also increases vagal tone by a central action. Eur J Pharmacol. 1988 Jul 14;151(3):373–379. doi: 10.1016/0014-2999(88)90533-x. [DOI] [PubMed] [Google Scholar]
  249. Ramsay R. R., Salach J. I., Singer T. P. Uptake of the neurotoxin 1-methyl-4-phenylpyridine (MPP+) by mitochondria and its relation to the inhibition of the mitochondrial oxidation of NAD+-linked substrates by MPP+. Biochem Biophys Res Commun. 1986 Jan 29;134(2):743–748. doi: 10.1016/s0006-291x(86)80483-1. [DOI] [PubMed] [Google Scholar]
  250. Rapoport R. M., Ashraf M., Murad F. Effects of melittin on endothelium-dependent relaxation and cyclic GMP levels in rat aorta. Circ Res. 1989 Mar;64(3):463–473. doi: 10.1161/01.res.64.3.463. [DOI] [PubMed] [Google Scholar]
  251. Rees D. D., Palmer R. M., Hodson H. F., Moncada S. A specific inhibitor of nitric oxide formation from L-arginine attenuates endothelium-dependent relaxation. Br J Pharmacol. 1989 Feb;96(2):418–424. doi: 10.1111/j.1476-5381.1989.tb11833.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  252. Rees D. D., Palmer R. M., Hodson H. F., Moncada S. A specific inhibitor of nitric oxide formation from L-arginine attenuates endothelium-dependent relaxation. Br J Pharmacol. 1989 Feb;96(2):418–424. doi: 10.1111/j.1476-5381.1989.tb11833.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  253. Rees D. D., Palmer R. M., Hodson H. F., Moncada S. A specific inhibitor of nitric oxide formation from L-arginine attenuates endothelium-dependent relaxation. Br J Pharmacol. 1989 Feb;96(2):418–424. doi: 10.1111/j.1476-5381.1989.tb11833.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  254. Reeves J. J., Stables R. Effects of indomethacin, piroxicam and selected prostanoids on gastric acid secretion by the rat isolated gastric mucosa. Br J Pharmacol. 1985 Nov;86(3):677–684. doi: 10.1111/j.1476-5381.1985.tb08945.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  255. Richardson B. P., Engel G., Donatsch P., Stadler P. A. Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugs. Nature. 1985 Jul 11;316(6024):126–131. doi: 10.1038/316126a0. [DOI] [PubMed] [Google Scholar]
  256. Richardt G., Waas W., Kranzhöfer R., Mayer E., Schömig A. Adenosine inhibits exocytotic release of endogenous noradrenaline in rat heart: a protective mechanism in early myocardial ischemia. Circ Res. 1987 Jul;61(1):117–123. doi: 10.1161/01.res.61.1.117. [DOI] [PubMed] [Google Scholar]
  257. Rink T. J., Smith S. W., Tsien R. Y. Cytoplasmic free Ca2+ in human platelets: Ca2+ thresholds and Ca-independent activation for shape-change and secretion. FEBS Lett. 1982 Nov 1;148(1):21–26. doi: 10.1016/0014-5793(82)81234-9. [DOI] [PubMed] [Google Scholar]
  258. Rodgers R. J., Shepherd J. K. 5HT1A agonist, 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT), inhibits non-opioid analgesia in defeated mice: influence of route of administration. Psychopharmacology (Berl) 1989;97(2):163–165. doi: 10.1007/BF00442242. [DOI] [PubMed] [Google Scholar]
  259. Rosengarten H., Schweitzer J. W., Friedhoff A. J. Induction of oral dyskinesias in naive rats by D1 stimulation. Life Sci. 1983 Dec 19;33(25):2479–2482. doi: 10.1016/0024-3205(83)90155-8. [DOI] [PubMed] [Google Scholar]
  260. Ross C. A., Ruggiero D. A., Joh T. H., Park D. H., Reis D. J. Adrenaline synthesizing neurons in the rostral ventrolateral medulla: a possible role in tonic vasomotor control. Brain Res. 1983 Aug 29;273(2):356–361. doi: 10.1016/0006-8993(83)90862-4. [DOI] [PubMed] [Google Scholar]
  261. Ruffolo R. R., Jr, Sulpizio A. C., Nichols A. J., DeMarinis R. M., Hieble J. P. Pharmacologic differentiation between pre- and postjunctional alpha 2-adrenoceptors by SK&F 104078. Naunyn Schmiedebergs Arch Pharmacol. 1987 Oct;336(4):415–418. doi: 10.1007/BF00164875. [DOI] [PubMed] [Google Scholar]
  262. Rupniak N. M., Jenner P., Marsden C. D. Acute dystonia induced by neuroleptic drugs. Psychopharmacology (Berl) 1986;88(4):403–419. doi: 10.1007/BF00178501. [DOI] [PubMed] [Google Scholar]
  263. Safer D. J., Allen R. P. The central effects of scopolamine in man. Biol Psychiatry. 1971;3(4):347–355. [PubMed] [Google Scholar]
  264. Salamone J. D., Beart P. M., Alpert J. E., Iversen S. D. Impairment in T-maze reinforced alternation performance following nucleus basalis magnocellularis lesions in rats. Behav Brain Res. 1984 Jul;13(1):63–70. doi: 10.1016/0166-4328(84)90030-5. [DOI] [PubMed] [Google Scholar]
  265. Savasta M., Dubois A., Benavidès J., Scatton B. Different plasticity changes in D1 and D2 receptors in rat striatal subregions following impairment of dopaminergic transmission. Neurosci Lett. 1988 Feb 15;85(1):119–124. doi: 10.1016/0304-3940(88)90440-5. [DOI] [PubMed] [Google Scholar]
  266. Sawada M., Ichinose M., Ito I., Maeno T., McAdoo D. J. Effects of 5-hydroxytryptamine on membrane potential, contractility, accumulation of cyclic AMP, and Ca2+ movements in anterior aorta and ventricle of Aplysia. J Neurophysiol. 1984 Feb;51(2):361–374. doi: 10.1152/jn.1984.51.2.361. [DOI] [PubMed] [Google Scholar]
  267. Schramm M., Thomas G., Towart R., Franckowiak G. Novel dihydropyridines with positive inotropic action through activation of Ca2+ channels. Nature. 1983 Jun 9;303(5917):535–537. doi: 10.1038/303535a0. [DOI] [PubMed] [Google Scholar]
  268. Schwartz J., Velly J. The beta-adrenoceptor of pig coronary arteries: determination of beta 1 and beta 2 subtypes by radioligand binding. Br J Pharmacol. 1983 Jun;79(2):409–414. doi: 10.1111/j.1476-5381.1983.tb11013.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  269. Schwartz R. H., Estroff T., Fairbanks D. N., Hoffmann N. G. Nasal symptoms associated with cocaine abuse during adolescence. Arch Otolaryngol Head Neck Surg. 1989 Jan;115(1):63–64. doi: 10.1001/archotol.1989.01860250065028. [DOI] [PubMed] [Google Scholar]
  270. Schümann H. J., Lues I. Postjunctional alpha-adrenoceptors in the isolated saphenous vein of the rabbit. Characterization and influence of angiotensin. Naunyn Schmiedebergs Arch Pharmacol. 1983 Aug;323(4):328–334. doi: 10.1007/BF00512471. [DOI] [PubMed] [Google Scholar]
  271. Scurlock J. E., Meymaris E., Gregus J. The clinical character of local anesthetics: a function of frequency-dependent conduction block. Acta Anaesthesiol Scand. 1978;22(6):601–608. doi: 10.1111/j.1399-6576.1978.tb01343.x. [DOI] [PubMed] [Google Scholar]
  272. Serrao J. M., Stubbs S. C., Goodchild C. S., Gent J. P. Intrathecal midazolam and fentanyl in the rat: evidence for different spinal antinociceptive effects. Anesthesiology. 1989 May;70(5):780–786. doi: 10.1097/00000542-198905000-00013. [DOI] [PubMed] [Google Scholar]
  273. Sharif N. A., Hunter J. C., Hill R. G., Hughes J. [125I]dynorphin(1-8) produces a similar pattern of kappa-opioid receptor labelling to [3H]dynorphin(1-8) and [3H]etorphine in guinea pig brain: a quantitative autoradiographic study. Neurosci Lett. 1988 Apr 12;86(3):272–278. doi: 10.1016/0304-3940(88)90495-8. [DOI] [PubMed] [Google Scholar]
  274. Sharma S. K., Bollands A. D., Davis S. S., Lowe K. C. Emulsified perfluorochemicals as physiological oxygen-transport fluids: assessment of a novel formulation. Adv Exp Med Biol. 1987;215:97–108. doi: 10.1007/978-1-4684-7433-6_12. [DOI] [PubMed] [Google Scholar]
  275. Sharma S. K., Bollands A. D., Davis S. S., Lowe K. C. Emulsified perfluorochemicals as physiological oxygen-transport fluids: assessment of a novel formulation. Adv Exp Med Biol. 1987;215:97–108. doi: 10.1007/978-1-4684-7433-6_12. [DOI] [PubMed] [Google Scholar]
  276. Sharp T., Maidment N. T., Brazell M. P., Zetterström T., Ungerstedt U., Bennett G. W., Marsden C. A. Changes in monoamine metabolites measured by simultaneous in vivo differential pulse voltammetry and intracerebral dialysis. Neuroscience. 1984 Aug;12(4):1213–1221. doi: 10.1016/0306-4522(84)90015-0. [DOI] [PubMed] [Google Scholar]
  277. Shimonkevitz R., Kappler J., Marrack P., Grey H. Antigen recognition by H-2-restricted T cells. I. Cell-free antigen processing. J Exp Med. 1983 Aug 1;158(2):303–316. doi: 10.1084/jem.158.2.303. [DOI] [PMC free article] [PubMed] [Google Scholar]
  278. Sim M. F., Yates D. B., Parkinson R., Cooling M. J. Cardiovascular effects of the novel arteriovenous dilator agent, flosequinan in conscious dogs and cats. Br J Pharmacol. 1988 Jun;94(2):371–380. doi: 10.1111/j.1476-5381.1988.tb11539.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  279. Solito E., Parente L. Modulation of phospholipase A2 activity in human fibroblasts. Br J Pharmacol. 1989 Mar;96(3):656–660. doi: 10.1111/j.1476-5381.1989.tb11865.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  280. Spencer D. G., Jr, Horváth E., Traber J. Direct autoradiographic determination of M1 and M2 muscarinic acetylcholine receptor distribution in the rat brain: relation to cholinergic nuclei and projections. Brain Res. 1986 Aug 13;380(1):59–68. doi: 10.1016/0006-8993(86)91429-0. [DOI] [PubMed] [Google Scholar]
  281. Stanton H. C. Selective metabolic and cardiovascular beta receptor antagonism in the rat. Arch Int Pharmacodyn Ther. 1972 Apr;196(2):246–258. [PubMed] [Google Scholar]
  282. Stephan H., Sonntag H., Schenk H. D., Kettler D., Khambatta H. J. Effects of propofol on cardiovascular dynamics, myocardial blood flow and myocardial metabolism in patients with coronary artery disease. Br J Anaesth. 1986 Sep;58(9):969–975. doi: 10.1093/bja/58.9.969. [DOI] [PubMed] [Google Scholar]
  283. Stolerman I. P., Fink R., Jarvik M. E. Acute and chronic tolerance to nicotine measured by activity in rats. Psychopharmacologia. 1973 Jun 29;30(4):329–342. doi: 10.1007/BF00429192. [DOI] [PubMed] [Google Scholar]
  284. Tada H., Shiho O., Kuroshima K., Koyama M., Tsukamoto K. An improved colorimetric assay for interleukin 2. J Immunol Methods. 1986 Nov 6;93(2):157–165. doi: 10.1016/0022-1759(86)90183-3. [DOI] [PubMed] [Google Scholar]
  285. Tamaoki T., Nomoto H., Takahashi I., Kato Y., Morimoto M., Tomita F. Staurosporine, a potent inhibitor of phospholipid/Ca++dependent protein kinase. Biochem Biophys Res Commun. 1986 Mar 13;135(2):397–402. doi: 10.1016/0006-291x(86)90008-2. [DOI] [PubMed] [Google Scholar]
  286. Taylor S. G., Weston A. H. Endothelium-derived hyperpolarizing factor: a new endogenous inhibitor from the vascular endothelium. Trends Pharmacol Sci. 1988 Aug;9(8):272–274. doi: 10.1016/0165-6147(88)90003-x. [DOI] [PubMed] [Google Scholar]
  287. Terrar D. A., Victory J. G. Effects of halothane on membrane currents associated with contraction in single myocytes isolated from guinea-pig ventricle. Br J Pharmacol. 1988 Jun;94(2):500–508. doi: 10.1111/j.1476-5381.1988.tb11553.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  288. Thomas G. R., Thiemermann C., Walder C., Vane J. R. The effects of endothelium-dependent vasodilators on cardiac output and their distribution in the anaesthetized rat: a comparison with sodium nitroprusside. Br J Pharmacol. 1988 Nov;95(3):986–992. doi: 10.1111/j.1476-5381.1988.tb11729.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  289. Toews M. L., Waldo G. L., Harden T. K., Perkins J. P. Relationship between an altered membrane form and a low affinity form of the beta-adrenergic receptor occurring during catecholamine-induced desensitization. Evidence for receptor internalization. J Biol Chem. 1984 Oct 10;259(19):11844–11850. [PubMed] [Google Scholar]
  290. Toll L., Snyder S. H. Solubilization and Characterization of Histamine H1 receptors in brain. J Biol Chem. 1982 Nov 25;257(22):13593–13601. [PubMed] [Google Scholar]
  291. Treherne J. M., Young J. M. [3H]-(+)-N-methyl-4-methyldiphenhydramine, a quaternary radioligand for the histamine H1-receptor. Br J Pharmacol. 1988 Jul;94(3):797–810. doi: 10.1111/j.1476-5381.1988.tb11591.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  292. Trimmer P. A., McCarthy K. D. Immunocytochemically defined astroglia from fetal, newborn and young adult rats express beta-adrenergic receptors in vitro. Brain Res. 1986 Jun;392(1-2):151–165. doi: 10.1016/0165-3806(86)90241-5. [DOI] [PubMed] [Google Scholar]
  293. Tutwiler G. F., Kirsch T., Bridi G. A pharmacologic profile of McN-3495 [N-(1-methyl-2-pyrrolidinylidene)-N'-phenyl-1-pyrrolidinecarboximidamide], a new, orally effective hypoglycemic agent. Diabetes. 1978 Aug;27(8):856–867. doi: 10.2337/diab.27.8.856. [DOI] [PubMed] [Google Scholar]
  294. Unger T., Ganten D., Lang R. E., Schölkens B. A. Is tissue converting enzyme inhibition a determinant of the antihypertensive efficacy of converting enzyme inhibitors? Studies with the two different compounds, Hoe498 and MK421, in spontaneously hypertensive rats. J Cardiovasc Pharmacol. 1984 Sep-Oct;6(5):872–880. doi: 10.1097/00005344-198409000-00021. [DOI] [PubMed] [Google Scholar]
  295. Vallar L., Meldolesi J. Mechanisms of signal transduction at the dopamine D2 receptor. Trends Pharmacol Sci. 1989 Feb;10(2):74–77. doi: 10.1016/0165-6147(89)90082-5. [DOI] [PubMed] [Google Scholar]
  296. Van Peer A. P., Belpaire F. M. Hepatic oxidative drug metabolism in rats with experimental renal failure. Arch Int Pharmacodyn Ther. 1977 Aug;228(2):180–183. [PubMed] [Google Scholar]
  297. Verbeuren T. J., Jordaens F. H., Zonnekeyn L. L., Van Hove C. E., Coene M. C., Herman A. G. Effect of hypercholesterolemia on vascular reactivity in the rabbit. I. Endothelium-dependent and endothelium-independent contractions and relaxations in isolated arteries of control and hypercholesterolemic rabbits. Circ Res. 1986 Apr;58(4):552–564. doi: 10.1161/01.res.58.4.552. [DOI] [PubMed] [Google Scholar]
  298. Vigne P., Frelin C., Cragoe E. J., Jr, Lazdunski M. Ethylisopropyl-amiloride: a new and highly potent derivative of amiloride for the inhibition of the Na+/H+ exchange system in various cell types. Biochem Biophys Res Commun. 1983 Oct 14;116(1):86–90. doi: 10.1016/0006-291x(83)90384-4. [DOI] [PubMed] [Google Scholar]
  299. Vincent J. E., Wallenburg H. C., Zijlstra F. J. Effect of prostaglandin F2 alpha, prostacyclin, and leukotriene C4 on the contractile activity of human uterine arteries. Adv Prostaglandin Thromboxane Leukot Res. 1983;12:417–422. [PubMed] [Google Scholar]
  300. Voulgari F., Cummins P., Gardecki T. I., Beeching N. J., Stone P. C., Stuart J. Serum levels of acute phase and cardiac proteins after myocardial infarction, surgery, and infection. Br Heart J. 1982 Oct;48(4):352–356. doi: 10.1136/hrt.48.4.352. [DOI] [PMC free article] [PubMed] [Google Scholar]
  301. Vyas I., Heikkila R. E., Nicklas W. J. Studies on the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: inhibition of NAD-linked substrate oxidation by its metabolite, 1-methyl-4-phenylpyridinium. J Neurochem. 1986 May;46(5):1501–1507. doi: 10.1111/j.1471-4159.1986.tb01768.x. [DOI] [PubMed] [Google Scholar]
  302. Wakade A. R., Wakade T. D. Mechanism of presynaptic actions of adenosine and acetylcholine on noradrenaline release in the guinea-pig heart. Neuroscience. 1982;7(9):2267–2276. doi: 10.1016/0306-4522(82)90137-3. [DOI] [PubMed] [Google Scholar]
  303. Waldman S. A., Murad F. Cyclic GMP synthesis and function. Pharmacol Rev. 1987 Sep;39(3):163–196. [PubMed] [Google Scholar]
  304. Walker A. G., Chapman J., Bruce C. B., Rumsby M. G. Immunocytochemical characterisation of cell cultures grown from dissociated 1-2-day post-natal rat cerebral tissue. A developmental study. J Neuroimmunol. 1984 Nov;7(1):1–20. doi: 10.1016/s0165-5728(84)80002-8. [DOI] [PubMed] [Google Scholar]
  305. Wamsley J. K., Gehlert D. R., Roeske W. R., Yamamura H. I. Muscarinic antagonist binding site heterogeneity as evidenced by autoradiography after direct labeling with [3H]-QNB and [3H]-pirenzepine. Life Sci. 1984 Apr 2;34(14):1395–1402. doi: 10.1016/0024-3205(84)90012-2. [DOI] [PubMed] [Google Scholar]
  306. Wanke E., Ferroni A., Malgaroli A., Ambrosini A., Pozzan T., Meldolesi J. Activation of a muscarinic receptor selectively inhibits a rapidly inactivated Ca2+ current in rat sympathetic neurons. Proc Natl Acad Sci U S A. 1987 Jun;84(12):4313–4317. doi: 10.1073/pnas.84.12.4313. [DOI] [PMC free article] [PubMed] [Google Scholar]
  307. Wanless R. B., Anand I. S., Poole-Wilson P. A., Harris P. An experimental model of chronic cardiac failure using adriamycin in the rabbit: central haemodynamics and regional blood flow. Cardiovasc Res. 1987 Jan;21(1):7–13. doi: 10.1093/cvr/21.1.7. [DOI] [PubMed] [Google Scholar]
  308. Ward-Routledge C., Marshall P., Marsden C. A. Involvement of central alpha- and beta-adrenoceptors in the pressor response to electrical stimulation of the rostral ventrolateral medulla in rats. Br J Pharmacol. 1988 Jun;94(2):609–619. doi: 10.1111/j.1476-5381.1988.tb11567.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  309. Ward S. G., Cantrell D., Westwick J. Inhibition by staurosporine of mitogen-induced calcium mobilisation in human T lymphoblasts. FEBS Lett. 1988 Nov 7;239(2):363–366. doi: 10.1016/0014-5793(88)80952-9. [DOI] [PubMed] [Google Scholar]
  310. Warner T. D., de Nucci G., Vane J. R. Rat endothelin is a vasodilator in the isolated perfused mesentery of the rat. Eur J Pharmacol. 1989 Jan 17;159(3):325–326. doi: 10.1016/0014-2999(89)90167-2. [DOI] [PubMed] [Google Scholar]
  311. Wassermann K., Huss R., Kullmann R. Dopamine-induced diuresis in the cat without changes in renal hemodynamics. Naunyn Schmiedebergs Arch Pharmacol. 1980 May;312(1):77–83. doi: 10.1007/BF00502578. [DOI] [PubMed] [Google Scholar]
  312. Westfall T. C. Effect of nicotine and other drugs on the release of 3H-norepinephrine and 3H-dopamine from rat brain slices. Neuropharmacology. 1974 Aug;13(8):693–700. doi: 10.1016/0028-3908(74)90015-x. [DOI] [PubMed] [Google Scholar]
  313. Whalley E. T., White S. K. Comparison of various prostaglandins (PG's) on the in vitro longitudinal uterine smooth muscle of the rat and guinea-pig. Br J Pharmacol. 1980 Jan;68(1):150P–151P. [PMC free article] [PubMed] [Google Scholar]
  314. Whelpton R. Iterative least squares fitting of pH-partition data. Trends Pharmacol Sci. 1989 May;10(5):182–183. doi: 10.1016/0165-6147(89)90233-2. [DOI] [PubMed] [Google Scholar]
  315. Wilhelmsson L., Lindblom B., Wikland M., Wiqvist N. Effects of prostaglandins on the isolated uterine artery of nonpregnant women. Prostaglandins. 1981 Aug;22(2):223–233. doi: 10.1016/0090-6980(81)90037-x. [DOI] [PubMed] [Google Scholar]
  316. Williams S. H., Constanti A. A quantitative study of the effects of some muscarinic antagonists on the guinea-pig olfactory cortex slice. Br J Pharmacol. 1988 Apr;93(4):855–862. doi: 10.1111/j.1476-5381.1988.tb11472.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  317. Wilson C. Inhibition by sulphonylureas of vasorelaxation induced by K+ channel activators in vitro. J Auton Pharmacol. 1989 Feb;9(1):71–78. doi: 10.1111/j.1474-8673.1989.tb00198.x. [DOI] [PubMed] [Google Scholar]
  318. Wong E. H., Knight A. R., Woodruff G. N. [3H]MK-801 labels a site on the N-methyl-D-aspartate receptor channel complex in rat brain membranes. J Neurochem. 1988 Jan;50(1):274–281. doi: 10.1111/j.1471-4159.1988.tb13260.x. [DOI] [PubMed] [Google Scholar]
  319. Woodcock E. A., Arnolda L., McGrath B. P. Ventricular beta-adrenoceptors in adriamycin-induced cardiomyopathy in the rabbit. J Mol Cell Cardiol. 1988 Sep;20(9):771–777. doi: 10.1016/s0022-2828(88)80002-6. [DOI] [PubMed] [Google Scholar]
  320. Yakubu M. A., Hamilton C. A., Howie C. A., Reid J. L. Idazoxan and brain alpha 2-adrenoceptors in the rabbit. Brain Res. 1988 Nov 1;463(2):289–295. doi: 10.1016/0006-8993(88)90402-7. [DOI] [PubMed] [Google Scholar]
  321. Yanagisawa M., Inoue A., Ishikawa T., Kasuya Y., Kimura S., Kumagaye S., Nakajima K., Watanabe T. X., Sakakibara S., Goto K. Primary structure, synthesis, and biological activity of rat endothelin, an endothelium-derived vasoconstrictor peptide. Proc Natl Acad Sci U S A. 1988 Sep;85(18):6964–6967. doi: 10.1073/pnas.85.18.6964. [DOI] [PMC free article] [PubMed] [Google Scholar]
  322. Yanagisawa M., Kurihara H., Kimura S., Tomobe Y., Kobayashi M., Mitsui Y., Yazaki Y., Goto K., Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1988 Mar 31;332(6163):411–415. doi: 10.1038/332411a0. [DOI] [PubMed] [Google Scholar]
  323. Yanagisawa M., Kurihara H., Kimura S., Tomobe Y., Kobayashi M., Mitsui Y., Yazaki Y., Goto K., Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1988 Mar 31;332(6163):411–415. doi: 10.1038/332411a0. [DOI] [PubMed] [Google Scholar]
  324. Yanagisawa M., Kurihara H., Kimura S., Tomobe Y., Kobayashi M., Mitsui Y., Yazaki Y., Goto K., Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1988 Mar 31;332(6163):411–415. doi: 10.1038/332411a0. [DOI] [PubMed] [Google Scholar]
  325. Yanagisawa M., Kurihara H., Kimura S., Tomobe Y., Kobayashi M., Mitsui Y., Yazaki Y., Goto K., Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1988 Mar 31;332(6163):411–415. doi: 10.1038/332411a0. [DOI] [PubMed] [Google Scholar]
  326. Yates M. S., Critchley M. A., Askey E. A., Bowmer C. J. Cardiac reactivity in rats with acute renal failure. J Pharm Pharmacol. 1985 Mar;37(3):175–179. doi: 10.1111/j.2042-7158.1985.tb05035.x. [DOI] [PubMed] [Google Scholar]
  327. Yocca F. D., Hyslop D. K., Smith D. W., Maayani S. BMY 7378, a buspirone analog with high affinity, selectivity and low intrinsic activity at the 5-HT1A receptor in rat and guinea pig hippocampal membranes. Eur J Pharmacol. 1987 Jun 4;137(2-3):293–294. doi: 10.1016/0014-2999(87)90241-x. [DOI] [PubMed] [Google Scholar]
  328. Yusof A. P., Coote J. H. Excitatory and inhibitory actions of intrathecally administered 5-hydroxytryptamine on sympathetic nerve activity in the rat. J Auton Nerv Syst. 1988 Apr;22(3):229–236. doi: 10.1016/0165-1838(88)90111-7. [DOI] [PubMed] [Google Scholar]
  329. Zigmond R. E. Tyrosine hydroxylase activity in noradrenergic neurons of the locus coeruleus after reserpine administration: sequential increase in cell bodies and nerve terminals. J Neurochem. 1979 Jan;32(1):23–29. doi: 10.1111/j.1471-4159.1979.tb04505.x. [DOI] [PubMed] [Google Scholar]
  330. Zipser R. D., Smorlesi C. Regulation of urinary thromboxane B2 in man: influence of urinary flow rate and tubular transport. Prostaglandins. 1984 Feb;27(2):257–271. doi: 10.1016/0090-6980(84)90078-9. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES